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Abstract
Ventilator associated pneumonia (VAP), a major source of infection in Intensive Care Unit
(ICU) that leads to higher mortality and cost. The PICO format is: Population: Adults with
endotracheal tube (ETT) intubations during ICU stay. Intervention: The ® Kimberly Clark High
Volume Low Pressure Micro Cuffed (KC) ETT for adults intubated in ICU. Comparison: The
High Volume Low Pressure ETT ®Mallinckrodt (MK). Outcome: Reduce VAP incidence and
improve patient outcomes. Do ICU adults intubated with KC ETTs have fewer VAPs than those
intubated with the MK? VAP starts with pathogen’s (Craven, 2006). Deem and Treggiari (2010)
believes the ETT does impacts this pneumonia. Spiegel (2010) feels the newer cuffed ETTs seals
the trachea, reducing aspirations, and that reduces VAP. Did the KC ETT decrease VAP
incidence, compared to the MK? The main objectives are to determine if there are decreased
VAPs with the KC ETT compared to the MK. Did compliance to the VB remain 100%, and did
the number of ventilator days make any difference in the two ETTs and VAP rates. A descriptive
retrospective data showed no significant difference in the number of VAPs based on the ETTs.
There were more ventilator days with the KC; 821 than the MK at 580 indicating a difference
between the number of ventilator days. The VAP rates for MK 1.7, the KC was 2.4. VB
compliance did remain100%.
Key words: VAP, ETTs design, Kurt Lewin CT, DNP Capstone Project
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EXECUTIVE SUMMARY
Problem
The practice issue is, that even with ventilator bundles (VB) at 100% compliance, ventilator
associated pneumonia (VAP) is a major source of infection in the Intensive Care Unit (ICU), and
leads to higher mortality and cost in the intubated adult patient. The PICO format is: Population:
Adults with endotracheal tube (ETT) intubations during ICU stay. Intervention: The ® Kimberly
Clark High Volume Low Pressure Micro Cuffed (KC) ETT for adults intubated in ICU.
Comparison: The High Volume Low Pressure ETT the ®Mallinckrodt (MK). Outcome: Reduce
VAPs in ICU and improve patient outcomes. While in ICU, do adults intubated with KC ETTs
have fewer VAPs than those intubated with the MK? Evidence shows that VAP starts with
pathogen’s (Craven, 2006). Deem and Treggiari (2010) agree, and supports VAP prevention at
the time of the intubation and believes the design of the ETT impacts VAP incidence. Spiegel
(2010) supports the use of the KC ETT and feels this newer cuff seals the trachea better and
reduces aspirations, and that reduces VAP.
Purpose
The purpose of the Capstone Project (CP) was to determine if the KC ETT resulted in a decrease
in VAP incidence, compared to the MK. Investigation into the role that the ETT plays in the
reduction of a VAP must continue to be pursued.
Goal
The main goal to provide the best evidenced based practice (EBP) interventions to assure the
most favorable outcome to the intubated and mechanically ventilated (MV) adult ICU patient.
Objectives
The main objectives were to determine if there are decreased VAPs with the KC ETT compared
to the MK. Did compliance to the VB remain 100%, and did the number of ventilator days make
any difference in the two ETTs and VAP rates.
Plan
Outcome plans: evaluate equally in twelve month periods the KC and MK on VAP incidence,
VB compliance, ventilator days and VAP rates in the KC and MK in comparative periods.
Application of the two-sample t-test, p value of .05, and a confidence interval of 95%, used to
aid in the analysis, reliability and validity of the findings, and in the interpretation of the results
of the outcomes identified. All findings will be disseminated.
Outcomes and Results
The CP results using the two sample t-test showed that there was no significant difference in the
number of VAPs based on the two ETTs; there were more ventilator days with the KC at 821
than the MK at 580 which indicates there was a significant difference between the numbers of
ventilator days. The VAP rates/1000ventilator days, for the two ETTs were as follows: MK VAP
rate was 1.7 and the KC was a 2.4 VAP rate. In addition, the VB compliance remained at 100%
for both 12 month time periods.
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Use of High Volume Low Pressure Microcuffed Endotracheal Tubes to Reduce Ventilator
Associated Pneumonia.
What is a Capstone Project (CP) and how does it relate to preventing ventilator associated
pneumonias (VAP)? The CP is the final step of the Doctorate of Nursing Practice (DNP)
program. It is reflecting a demonstration of synthesis and mastery of an advanced subject within
the practice of nursing by the student completing their final academic steps (Zaccagnini &
White, 2011). The purpose of a CP is to improve a practice and or a patient care outcome, and
also set the tone for continuous improvement through evidence based practice (EBP)
interventions (Zaccagnini & White, 2011).
The purpose of this project and paper was to provide in writing the CP problem recognition
and definition, review of evidence, project plan and evaluation, project findings and results,
limitations, recommendations, and implications for change with the aim of determining if the
evidence indicates that the use of the newer designed endotracheal tubes (ETTs) did result in
decreased VAP incidence and did promote better patient care outcomes.
Problem Recognition and Definition
Statement of Purpose Appropriate for Evidence-based Project
The main purpose of this CP was to ascertain whether there is strong evidence to support the
use of newer designed ETT like the polyurethane ®Kimberly Clark high volume low pressure
microcuffed (KCHVLPMC) ultrathin tube in decreasing VAP rates, compared to other high
volume low pressure tube designs like the ®Mallinckrodt (MK). In addition, did investigation
into the role that the two ETT designs play in the reduction of VAPs need to be pursued further.
This could possibly save lives, decrease mortality and morbidity, reduce health care costs, and
hospital days and result in better patient care outcomes.

1
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Problem Statement/Change Clearly Identified
Starting out with the practice issue of concern, and using the recognized abbreviation PICO
which includes the Population of concern, Intervention, Comparison method, and Outcome
(PICO); a PICO statement was created, data was collected that could possibly support changes in
practice that are evidence based and best practice methods, thus resulting in better patient care
outcomes. The problem issue clearly identified was that there remains an increased incidence of
VAP in spite of ventilator bundle (VB) protocols and 100% ventilator quality indicator (QI)
compliance, and other EBP strategies. Based upon the evidence VAP is still occurring and
remains a leading cause of hospital acquired infections (HAIs) (Bird, Zambuto, O’Donnel, Silva,
Korn, Burke, Burke, & Agarwal, 2010). Further inquiry into the problem issue was constructed
as an EBP question and included the patient population, intervention, comparison, and outcome,
known as PICO.
PICO Articulated and Leads to Question
The PICO Format: In adult patients undergoing oral intubation while hospitalized in Intensive
Care Unit (ICU), do patients who are orally intubated with the KCHVLPMC ETT have fewer
VAPs than those who are intubated with other high volume low pressure ETTs like the MK? The
PICO format is:
P-Population: Adults with oral ETT intubations during ICU hospitalization.
I-Intervention: Use of improved KCHVLPMC ETT for adult oral intubations in ICU.
C-Comparison: Another high volume low pressure ETT like the MK.
O-Outcome: Reduce or eliminate all incidences of VAP in ICU and provide better
patient care outcomes.

NR706C_PageJo_wk8CAPSTONE PROJECT

3

The final question is: In adult ICU patients undergoing oral intubation while
hospitalized in ICU, do patients who are orally intubated with the KCHVLPMC ETT have fewer
VAPs than those who are intubated with other commercially designed high volume low pressure
ETTs?
Project Significance, Scope, and Rationale
The project significance is VAP continues to be a major infection in ICU, leading to higher
morbidity and mortality and an overwhelming health care cost factor in the intubated adult
patient population. Conducting this CP was an exceptional opportunity to possible play an
important part in reducing the occurrence of this pneumonia. VAP is linked with the ETT
instrumentation used to maintain the airway (Deem & Treggiari, 2010). The ETT can contribute
to the aspiration of infected secretions that can establish just the right environment for a VAP to
develop (Deem & Treggiari, 2010). It is critical that future research into the effects the ETT
design has on the prevention of VAP be continued (Deem & Treggiari, 2010). It is equally
important that future studies of ETTs designed to prevent VAP demonstrate effectiveness, and
show evidence of improved patient care outcomes, safety, and cost (Deem & Treggiari, 2010). A
multifaceted approach that includes the use of the ventilator bundle (VB) along with the
initiation of the newer designed KCHVLPMC ETT may reduce VAP incidence and this method
should be investigated further to determine its effectiveness and, that was the main rationale for
this CP. Add to this, all VAP incidences from hospitals are also reported to the Center for
Disease Control and Prevention (CDC) and are available to the community for viewing. This
data is often used by the public when choosing a hospital for care delivery. Preventing VAP is a
huge priority in ICU and adding to this precedence is the pressure being put on hospitals to
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eliminate HAIs like VAP or face reductions in reimbursement from health insurance providers
like Medicare and Medicaid and others (Bird et al., 2010).
Evidence suggests a VAP starts with a host factor and pathogen (Craven, 2006). Knowing
this, several different prevention guidelines must be initiated at the time of the intubation.
Pulmonary experts like Deem and Treggiari (2010) and Blot, Rello, and Vogelaers (2011) agree
guidelines should focus on reducing the host factor and colonization of pathogens that contribute
to a VAP. Craven (2006) realized prevention of aspiration into the lung field, effective antibiotic
treatment, limited, or omitting the use of invasive devices such as nasal intubation and gastric
tubes are areas for primary focus.
Even with the initiation of preventive measures and the development of VAP standing orders,
hospitals still have not reached the expected number of reduced occurrences. The evidence
suggests perhaps the design of the ETT being used for intubations may be a contributing factor to
the lack of reduction of VAP incidence. However, Spiegel (2010) reports not being convinced
that changing the design or contour of the ETT will reduce the VAP occurrences but does feel
there is merit in changes in the cuff design which may improve sealing the trachea area better.
This may reduce aspiration of contaminated secretions, which in turn may decrease VAP
occurrences.
The KCHVLPMC ETT is an ultrathin high volume ultra low pressure cuff specifically
invented to be above average in sealing the trachea location (Spiegel, 2010). Lorente, Blot, and
Rello (2010) reports newer strategies such as the design of a ETT that is an ultrathin cuffed and
low-volume low pressure cuff device is also being investigated as a possible answer to the
reduction of VAP incidence. In 2008, a study conducted at a hospital in Tampa, Florida using the
KCHVLPMC ETT demonstrated a 60% drop in VAP’s as reported by the Head of Anesthesia
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(Karlnoski, Kolla, Munoz, Downes, Thompson, Klacsan, & Kelley, n.d.). Spiegel (2010) also
reported this ETT showed a 43% decrease in VAP incidence. On the basis of this evidence and
support, there is justification for further research into what is best in practice, and it should be
pursued.
Theoretical Foundation for Project and Change
The theoretical foundation for the CP and any possible change in practice incorporates the
use of the Kurt Lewin change theory (CT) known as unfreeze, change, and refreeze stages and
would contribute even further in the successful implementation of EBP changes that promote the
best patient outcome. The best patient care outcome would be recognized as evident by the
reduction of VAP occurrences in ICU. First, unfreeze the present practice which was done in
January 2012 when the KCHVLPMC ETT replaced the MK ETT. Next, make the change, which
was done and started January 2012 with the implementation of the KC tube for all adult
intubations, and evaluate the outcome over a stated period of time. If the change results in a
reduction of VAP incidence and better patient care outcomes were achieved, refreeze the practice
and keep the KCHVLP ETT. Next, it would be important to establish procedures and policies to
preserve the practice until another change is deemed necessary (Kaminski, 2011).
Literature Selection/Systematic Review of Literature/Process Supports Problem
A literature selection and systematic process supporting the VAP problem was conducted.
The literature subject goal of the CP was to address the problems associated with VAP incidence,
and to better understand the difficulties involved, in hope of finding improved EBP interventions
that contribute to the best outcome possible for the patient. An extensive literature review by
means of a systematic process was conducted over the entire course of the DNP program. Using
databases such as PUBMED, CIHNAL, MD Consult, Cochrane, MEDLINE Agency for
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Healthcare Quality and Research (AHRQ) and searching key words including ETT designs, VAP
prevention, VB protocol, EBP, CDC definition of a VAP and Kurt Lewin’s CT, and searching
for levels of evidence that included levels I, II, III, IV, and V, and that were creditable based on
systematic reviews, meta-analysis, randomized control trials (RCT), or evidence of one or more
RCTs, case studies, qualitative studies or expert opinions. Included in this paper is the systematic
review carried out to support the CP problem and practice issue of on-going VAP incidence
(Appendix A). Need to add a sentence here that states the number of articles you found, how you
narrow and your final number of articles included in your review and application to this project.
Scope of Evidence is Summarized and Appropriate
The scope of evidence summation clearly reveals the practice issue of concern, which is
VAP continues to be a major source of HAI in ICU, and contributes to higher morbidity and
mortality and an overwhelming health care costs in this intubated adult patient population. The
evidence is strong that a VAP starts with a host factor and pathogen. Knowing this, several
different prevention guidelines must be initiated at the time of the intubation. These guidelines
should focus on reducing the host factor and colonization of pathogens that contribute to a VAP.
As stated earlier, Craven (2006) did realize prevention of aspiration into the lung field, antibiotic
treatment, and limiting or omitting the use of invasive devices such as nasal intubations, nasal
gastric tubes, and even central venous lines inserted up at the neck location are areas that must be
of primary focus.
Even with the initiation of preventive measures, and the development of VAP standing orders,
hospitals still have not reached the expected number of reduced occurrences, which is set at
reaching a zero in events (Wahl, Zalewski, & Hemmila, 2011). The evidence continues to
support that perhaps the design of the ETT being used for intubations may be a contributing
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factor to the lack of reduction in VAP incidence. As has been noted, Spiegel (2010) is not yet
convinced changing the design or contour of the ETT will reduce the VAP occurrences but does
feel there is merit in changes in the cuff design which has shown improved sealing of the trachea
area better, and this may reduce aspiration of contaminated secretions, and that may decrease this
type of pneumonia.
The KCHVLP ETT is an ultra low pressure cuff specifically invented to be above average in
sealing in the trachea and, Spiegel, (2010) believes this is reducing the aspiration of
contaminated secretions that contribute to VAP. Lorente, Blot, and Rello (2010) reported that
newer strategies such as the design of ETT to be ultrathin cuffed and low-volume low pressure
cuff devices are also a possible answer to the reduction of VAP because it too has demonstrated
a reduction of the aspiration of these infected secretions. It is evident that further research into
what is best in practice should be pursued. If the hospital in Florida who reported after using the
KCHVLPMC ETT in practice showed a 60% drop in VAPs perhaps more healthcare facilities
could as well.
Review of Evidence
Background of the Problem
The literature review on the background and problem of continued and persistent VAP
incidence was executed. It concludes, in spite of the current strategies to prevent VAP in the
mechanical ventilated (MV) adult ICU patient, this pneumonia remains the second most common
HAI and carries a high mortality rate (Blot et al., 2011). It is an all encompassing and costly HAI
is significantly related with the invasion of the ETT instrument used to maintain an airway (Blot
et al., 2011). Contaminated secretions or fluids can bypass the ETT cuff and establish an
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environment in the lungs is right for bacterial infections to grow and develop into a VAP (Blot et
al., 2011).

Systematic Review of the Literature
The systematic review of the literature substantiated that VAP is a hospital acquired
pneumonia (HAP) and could affect a great number of people in the 18 years or older age group
and rise significantly in the 65+ age group. It is one of the most common HAI in adult ICUs and
a significant concern of clinicians today (Bird et al., 2010). It may account for up to 60 percent
of all deaths from HAIs in the United States (U.S.) (Bird et al. 2010). Other key U.S. statistics
includes the following: Approximately eight to 28 percent of critical care patients intubated
during their stay in ICU will develop a VAP (Bird et al. 2010). This patient population carries a
mortality rate of 15 to 25 percent (Bird et al., 2010). Add to this, mortality and morbidity of a
VAP can be induced by other unpredictable variables which can affect this patient population,
such as the timing of the onset of pneumonia, other diagnostic lines of attack, other contributing
organism, and delays of needed interventions (Bird et al., 2010). VAP also increases the adult
patient population time in the ICU by four to six days, and prevention of VAP is a main priority
in all ICUs throughout the nation (Bird et al., 2010). VAP though reduced in incidence has not
reached a zero percent rate. In some cases 10.2 VAP cases /1000 ventilator days has been
reported in some trauma ICUs (Bird et al., 2010). In spite of the current strategies to prevent
VAP in the MV adult ICU patient, this pneumonia still remains the second most common HAI
and still carries a high mortality rate (Blot et al. 2011). It is a costly HAI that is significantly
related with the invasion of the ETT instrument used to maintain an airway (Blot et al., 2011).
The contaminated secretions or fluids as already stated earlier can bypass the ETT cuff and
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establish an environment in the lungs that is right for infections to grow and develop into a VAP
(Blot et al., 2011). VAP prevention will most likely be best achieved by a multifaceted approach.
This means not only with the continuation of current VAP prevention strategies such as basic
infection control methods like excellent hand hygiene, proper patient positioning, effective
mouth care, early removal of the ETT, but also considering the use of the newer designed ETT
currently available and showing evidence of VAP incidence reduction.
Deem and Treiggari (2010) support the newer designed ETTs demonstrates evidence of VAP
reduction must continue to be explored. Deem and Treiggari (2010) also believes there is strong
support that further investigation into the effectiveness of current VAP prevention strategies
along with novel prevention strategies like the newer designed ETT must continue. It is possible
better patient care outcomes can be realized and reached with a multifaceted approach to VAP
prevention strategies (Deem & Treiggari, 2010).
In 2010, the U.S. Census Bureau reported that the age group 65 and older is growing faster
than the total U.S. population (United States Census Bureau, 2011). A hospital in the northern
section of the U.S. where the data for the CP was obtained is a state identified as having above
national average in the number of older adults 65+ age category (United States Census Bureau,
2011). The major population at risk for a VAP is the adult patient who requires oral intubation
while hospitalized in the ICU and was the key population of interest for the CP. This population
is also often prone to infection just by the nature of the stressful hospital environment.
Therefore, further investigation into the effectiveness of current VAP prevention strategies along
with novel prevention strategies like the newer designed ETT must be followed.
Project Plan and Evaluation
Market/Risk Analysis
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The strength, weakness, opportunity, and threat (SWOT) market/risk analysis was conducted
on the CP and did aid in identifying the driving and restraining forces of the project. A SWOT
analysis model was effective in guiding and identifying the health promotion and disease
prevention needs for the population identified as at risk for a VAP, which is the adult patient who
requires oral intubation while hospitalized in the ICU. Table 1 is the modified SWOT analysis
conducted to target VAP rate reduction. It contains the lists of the identified strengths,
weaknesses, opportunities, and threats that were the most beneficial acknowledgements utilized
when searching for the most effective VAP prevention strategies.
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Project Strength, Weaknesses, Opportunities, and Threats
Table 1.
SWOT Analysis

al
nr
<u
nI

Strengths:
• Staff at all levels of the organization are
ready to get serious about HAI and VAP
infection rates
• Policies and procedures to prevent the
spread of infection are being enforced
(Isolation). Hand washing before and
after contact with the patient (pt)
• Ventilator Bundles are automatically
initiated upon intubation followed by
mechanical ventilation
• Endotracheal tube to reduce VAP
incidence are trialed and used in all
departments who intubate pts.
• Reward system in place to reward doing
an excellent job and keeping the HAI
and VAP rates down
• Equipment and Technology

Weaknesses:
• Lack of sense of accountability from some
healthcare providers
• Ventilator Bundle implemented but not
followed with 100% compliance
• Staff cut corners and are resistant to change
( don’t follow isolation policies
consistently)
• Inadequate or inappropriate staffing ratios
• CDC guidelines for the definition of a VAP
vague and interpretation difficult and at
times challenged
• Visitors and family members are not
always supporting the cause to prevent the
spread of infection in the pt room
• Poor communication

al
nr
(U
nI

Opportunities:
• Patient and family involvement in
infection control
• Keep entire organization engaged with
changes in practice with effective and
ongoing communication and policing
each other
• Promote standardized practice for
cleaning a room while occupied and
after vacancy
• Get pharmacy involved and improve
effective antibiotic usage
• Provide regular updates on HAI and
VAP rates
• Re-evaluate rates and publish on a
community board with a data analysis
graphic chart
• Educate hospital associates in all
departments on the non-payment for
HAI occurring in the US hospitals
• Engage and involve multi-professional
rounding and include pt and family
• Literature Search for Best Practice
Protocols

Threats:
• Making public aware of HAI and VAP
rates when not favorable
• Financial ramification
• Other priorities competing for time and
resources
• Doing nothing until forced to change
• Lack of education of VAP threat
• Poor hand hygiene
• Poor compliance to
policies/procedures/protocols
• Poor staffing and ineffective leadership
• Lack of resources
• Other hospital departments that provide
care to the pt besides the ICU
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Driving/Restraining Forces
The driving force identified to implement the most current EBP VAP prevention strategies
was to assure the MV ICU patient receives the best patient outcome possible. The restraining
force to that possibility was identified and listed as weaknesses in the SWOT analysis, and was
seen in the supply and demand areas of manpower. Being able to sustain a full workforce of
qualified registered nurses (RN) and certified respiratory therapists (RT) was seen as a possible
concern. Retention and recruitment of such skilled professional staff members will always have
an impact on maintaining high quality care. The evidence indicates nurse-to-patient ratios are
directly correlated to patient care outcomes (Aiken, Clarke, Slogane, Lake, & Cheney, 2009). In
an effort to maintain high quality care to the MV patient in ICU ongoing efforts to retain and
recruit highly qualified professional staff remains a priority at the facility where the CP was
conducted in their 20 bed mixed ICU. Since a newly formed merger with a large healthcare
service organization in July 2012, the hospital where the CP was conducted currently remains
dedicated to providing their patients the best EBP care, which includes the use of the newer
designed KCHVLPMC ETT for all intubations performed in their ICU. As a result of this merger
a change in the ETT product other than the KCHVLPMC tube could be considered in the future,
regardless of the outcome of this project. To date it remains the ETT of choice and has been
throughout the CP process.
Need, Resources, and Sustainability
Vital implementation and ongoing monitoring of the project plan in order to facilitate any
requested changes was conducted, and was based on the need, resources, and sustainability of the
plan. The biggest need identified was the need to achieve Institution Review Board (IRB)
approvals from Regis University, and the hospital granting permission for the CP to be
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conducted on their adult MV ICU patient population and keep the CP on the proposed timetable
to be met. The resources in the form of data retrieval, and the staff who provided such for the CP
were provided in a timely fashion, and after IRB approvals had been granted. Based on the
ability to complete the CP in the time allotted sustainability was maintained with no real issues
experienced.
Feasibility/Risks/Unintended Consequences
The information achieved through the CP is feasible and applicable in the day to day care of
the MV patient and is currently being practiced in the ICU where the project was conducted. As
far as a risk benefit analysis there was no direct risk to the patient population that data was
collected on for the CP. All of the information collected came from a retrospective data source.
The greatest benefit is keeping MV patients from further VAP incidence; that starts on day one
with implementation of the VB. This includes assuring that the ventilator QI is done every day
and documentation of best strategies to prevent VAP occurrence are implemented and strictly
adhered to. There were no unintended consequences identified as a result of the CP data
collection process.
Stakeholders and Project Team
The author’s opinion is that stakeholders are seen as any person, group or organization,
members, or system that could be affected by an organization’s action. The stakeholders and
project team members of the CP associated with VAP prevention were recognized as the adult
ICU intubated patient and family members who were affected the most from the delivery of care
outcome. Next were the members of the VAP committee where the CP was conducted which
were, the Medical Director of Critical Care, the Director of Nursing, the Critical Care Unit
(CCU/ICU) Nurse Manager and Clinical Nurse Educator and Chairperson, the Respiratory
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Therapy Manager and Coordinator, the Infectious Disease (ID) Nurse, and at times the Chief
Nurse Officer (CNO) during a VAP occurrence investigation and review process. Also included
were the staff members in CCU/ICU, the organization, and the author’s mentor and chairperson
who provided guidance and support throughout the CP.
Cost/Benefit Analysis
A process that must be conducted when considering a practice change is the cost-benefit
analysis (Longest, 2010). One question to be considered is, can the organization substantiate the
higher cost that a newer designed ETT may carry? A comparison in cost of the old product, the
MK, to the newer KCHVLPMC tube was performed in 2010 at the facility where the CP was
conducted (B. Seward, personal communication, January 13, 2012). When compared in 2013
using hypothetically similar prices; the MK costing approximately two dollars per tube and the
KCHVLPMC model costing two dollars and forty cents per tube. The number of ventilator days
used was 821 days which was the number of days reported for 2012. The MK tube would have
had a cost of $1641.00 dollars. Comparatively, the KCHVLPMC model for the same 821
ventilator days costs $2070.00 dollars, a cost difference of $429.00 dollars. The cost of one VAP
is estimated to be $5000 to $25,000 for one incident (Bird et al., 2010). The cost of preventing
one VAP would clearly support an investment in the newer designed ETT. Zolfaghan and
Wyncoll (2011) states if a newer intervention, like implementing the use of the newly designed
Kimberly Clark ETT, reduces the VAP rate by a mere one percent, it would be worth the change
in practice. The staff involved with intubations required no additional training. Therefore, there
was no additional cost incurred in training or educating the departments or personnel, who were
responsible for these types of patients. The cost of orienting newer ICU employees in caring for
the MV Adult ICU patient remains included in the six week Critical Care Course (CCC) that all
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new graduate nurses must attend before working in the unit environment. The course costs
approximately $5700 and that covers approximately 8 participants per class.
When a nurse with prior experience or working at the facility where the CP was conducted
accepts a nursing position in the ICU they may choose to take certain topics of the CCC. All are
encouraged to take the pulmonary and cardiovascular topics, and must attend the 16 hour handson skill lab. Each topic alone will cost the hospital approximately $900 and the pulmonary topic
does include care of the MV adult ICU. The skill lab costs approximately $650 for both days.
Again, when compared to the cost of one VAP incidence these expenses are clearly worth the
investment.
Mission/Vision/Goals
A mission statement was essential in the CP, and it is short and concise and still remained a
simple thought, it was one that kept the mission alive and possible, and the focus meets the
present, as well as future strategic plans (Ward, 2013). The mission of the CP was “to create and
facilitate health care to the people being served” and that included all adult ICU patients
requiring intubation while in ICU.
A vision statement was also created and it is concise and easy to remember, it continued to
drive the goals and objectives needed to achieve the vision (Barker, 1992). The vision of the CP
was “to restore to health caringly, educate resourcefully, and to constantly give rise to better
patient care outcomes” through the use of EBP interventions. From time to time it was recapped
and that kept the staff where the CP was conducted engaged in the vision, and promoted the main
objective, which was and is to provide EBP care.
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The most important goal and objective of the CP was to determine if, along with current VAP
prevention strategies, did the use of the newer designed ETT like the KCHVLPMC reduce this
pneumonia, and did it provide a better patient care outcome. The common core ethical, personal,
and professional values of the CP included conducting everything concerned with the project,
through the endorsement of accountability, advocacy for the patients involved , integrity, respect,
honesty, resourcefulness, beneficence, justice, caring, dedication, collaboration with others,
compassion, and also embraced the provisions needed for the delivery of excellent healthcare
services to the MV patient population.
Process/Outcomes Objectives
The main objectives were to distinguish if there was a decrease in VAP incidence with the
KCHVLP ETT compared to the MK tube, thus resulting in decreased mortality, ventilator days,
VAP incidence, infections, and cost, and to conclude if there was increased compliance to the
VB and improved patient care outcomes. Outcome plans were to, evaluate equally in 12 month
periods the KCHVLPMC ETT and MK tube on VAP incidence, VB compliance, ventilator days,
and VAP incidence in the comparative periods. The ventilator benchmark for year January 2011
to December 2011 when the MK tube was used for intubations in ICU was, number of VAP
cases equal one, the number of ventilator days equals 580 (C. Parker, personal communication,
March 1, 2013) These are the benchmarks being compared for year January 2012 to December
2012 when the KCHVLPMC tube was put into practice for all adult intubations in ICU. VAP
where VAP cases equal two, and the number of ventilator days equals 821(C. Parker, personal
communication, March 1, 2013).
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As stated, the focus of the CP was to identify the measurable outcomes for the above selected
study population and determine if the goals were met. There are four main outcomes
measurements to be achieved.
First, assessment of the outcome measurement on the impact of product implementation using
the KCHVLPMC ETT for all adult patients in ICU requiring intubations, compared to the MK
ETT on the reduction in VAP incidence. The first and primary outcome measure will be the
relationship between the KCHVLPMC ETT in a 12 month period compared to the MK ETT in a
comparable period in VAP incidence in the ICU at the facility where the CP was conducted.
Second, assessing the compliance of all current VAP prevention strategies, which includes the
VB implementation at the time of intubation and data collected on the ventilator QI form by the
nursing staff. Third, look at the number of ventilator days in a 12 month period of time January,
2011 to December, 2011 for the MK ETT and January, 2012 when the KCHVLPMC ETT was
first implemented and the MK tube was removed from use to December, 2012. Fourth, the
number of VAP incidence in the same time period January, 2011 to December, 2011, and
January, 2012 through December, 2012. With exception of the ETT designs, the EBP strategies
to prevent VAP for both ETT time frames have remained the same such as: basic infection
control methods like excellent hand hygiene adherence, proper patient positioning that included
head of bed elevated greater than 30 degrees at all times, effective mouth care every two hours
with chlorahexadine teeth brushing every four hours, early removal of the ETT that includes
daily sedation breaks, and daily weaning parameters, and considering the use of the newer
designed ETT currently available and showing evidence of VAP incidence reduction.
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Logic Model
The intent of the evaluation plan on the CP outcomes was to visibly give detail to the
underlying association of relationships and a clear understanding of what is necessary to
ascertain the indifferent association of relationships. Even before the study on outcomes was
planned, the examiner needed to have a visual and mental picture of the outcomes of interest, and
the impact it will have on the associated relationships. The use of a conceptual model provided a
visual clear detail of association with the practice problem concerns, clinical factors, prevention
strategies, and outcomes (Kane, & Radosevich, 2011). Zaccagnini and White (2011) provided
the conceptual model used in the CP and the example of a logic model that was the expected
model by Regis University to be used in the project (Appendix B). This is an example of the
DNP process that did best guide the CP and was designed during the planning phase of the
project for evaluation purposes. The logic model contains the inputs outputs and outcomes all
parts found in most models and contains the components necessary for connecting the difference
parts of the project logically together thus providing an illustration of the progression that the
project did and was expected to take.
Appropriate for Objectives and Research Design
The research design was a retrospective data collection method. The data was obtained from
the CP conducting facility soon after the IRB of the hospital, and Regis University had approved
such. The project was officially declared exempt status by the University on February 18, 2013.
The evaluation plan was appropriate for the CP objectives stated above, and the methodology
design; a descriptive analysis of retrospective data comparison obtained from the 20 bed mixed
ICU. The set period of time January 1, 2011 to December 31, 2011 for the MK ETT and January
1, 2012 to December 31, 2012 for the KCHVLPMC ETT.
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To aid in data collection a example of a ventilator QI compliance chart indicating adherence
to the VB was made available by the facility where the CP was conducted. (Appendix C).
Compliance was documented as a yes or no for each ventilator (QI). Compliance calculations
were summarized monthly and data was provided monthly during the nursing staff meeting by
the CCU Nurse Manager who compiled the data for the ventilator QI. Compliance on the use of
the adopted KCHVLPMC ETT was compiled by the Manager of the Respiratory Care
Department and shared at the monthly VAP committee meeting.
Time Frame
The timeframe for the CP started in September 2011 in the DNP program course Theoretical
Application for Doctoral Nursing Practice, where the practice issue of concern, the problem
identification, PICO format was established and the final question to be investigated and
answered was created. Clinical rotations started in January 2012 and were completed this April
2013 where a total of 900 hours were performed in the Application to Practice Clinical Hours
courses required in the DNP program. In December 2012 the request for exempt status was
submitted to the Regis University IRB as part of the DNP Capstone Project course completed
that fall semester, and it was approved in February 2013 in spring DNP Capstone Project course.
Approval for data collection was granted in December 2012 by the IRB at the facility where the
CP was conducted. Data collection began in February 2013 and is now completed. The
timeframe for obtaining the retrospective data collection was from February 27, 2013 until May
31, 2013. The data was collected on time and tabulated with results known as of July 4th, 2013
(Appendix D).
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Budget and Resources
The budget issues associated with this CP were approximately $37,000 which is based on
another person conducting such work without being in a DNP program CP. Wages for the 900
hours of clinical alone would have been $36,000 based on a $40.00 an hour wage. Another
$1000 in expenses was allotted for travel, meals, library use, stationary and computer use, along
with the installation of the SPSS statistical tools, and extra reference books used to achieve the
CP literature reviews and additional academic information. The facility where the CP was
conducted has already removed the MK ETT from service availability, and had purchased and
placed the KCHVLPMC ETT into service availability prior to the project starting. The hospital
had completed a VAP timeline and the official change was initiated January 2011. There was no
additional education required for the implementation of this product. There were no additional
funding sources attached to this CP (Appendix E).
Population/Sampling Parameters
The population of interest for the CP came from a 20 bed ICU and a 150 bed acute care
facility. The population was all adult 18 years and older patients who were intubated during their
stay in ICU. Cases of VAP incidences were identified using the 2011 CDC criteria. Cases of
incidence were also scrutinized by the ID Nursing Department, VAP committee members and
the CNO of this facility. The plan for analysis was based on the dependent variable VAP
incidence, defined as: pneumonia in an adult patient intubated in ICU, and ventilated at the time
of or within 48 hours before the onset of the event. The MV patient had to present with at least
one of the following: fever > 100.4 degrees Fahrenheit with no other cause, leukopenia (<4000
WBC/mm3) or leukocytosis (> 12,000 WBC/mm3), and at least two of the following: new onset
of purulent sputum, or changes in character of sputum, or an increase in respiratory secretion
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needing more suctioning via the ETT or new onset of cough, dyspnea, tachypnea, or rales, or
worse gas exchange, oxygen (O2) desaturation, or increased demand for O2 or increased demand
for ventilator (Center for Disease Control and Prevention, 2011). Chest X-rays were obtained
and a newly developed infiltrate suspecting a recently developed pneumonia was given
consideration if the case was deemed a VAP. The new guidelines for a VAP according to the
CDC as of 2013 were not included in this definition but were compared on the cases deemed a
VAP from January 2012 to December 2012. The rate of VAP was defined as the number of VAP
cases per/year per/1000 ventilator days. Ventilator days were based on the number of days the
patient used the ventilator prior to extubation. Compliance of the VB was done randomly by the
nursing staff, and was conducted daily as part of the author’s clinical application during the DNP
Application to Practice courses. As stated previously, compliance was documented as a yes or no
on each ventilator (QI) completed and summarized monthly and the results provided monthly
during the nursing staff meetings.
Setting is Appropriate for EBP Project
The setting is appropriate for an EBP project based on the patient population of interest, the
final question to be answered, and the evidence gathered (Zaccagnini & White, 2011). There are
four outcomes to be achieved, first, the relationship between the KCHVLPMC ETT in a 12
month period compared to the MK ETT in a comparable period on VAP incidence. Second,
assess compliance of VAP prevention strategies, included in the VB from ventilator QI data
during both time periods of ETT s use. Third, calculate number of ventilator days over the same
periods of time. And fourth, calculate number of VAP incidence in the same time periods.
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EBP Design Methodology and Measurements Provided
The statistical software SPSS program was used in the predictive analysis aspect of the CP.
SPSS is a highly recognized computer program when calculating statistical data and predicting
outcomes (Polit. 2010). The two-sample t-tests using a probability value (p - value) based on
0.05 was a feature used on the SPSS computer program and was conducted along with the twosample t-tests for all data analysis. Ventilator QI and VAP incidence data was provided by the
Nurse Manager of the ICU during the time periods of both ETTs.
The two-sample t-test was used on three of the outcomes to indicate the mean of two normal
populations are really equal. A p-value of 0.05 results was used to support there was or was not a
difference in the two comparative ETTs. A p-value < than 0.05, indicates there was less
probability that the ETTs are the same in decreasing VAP. A p-value > than 0.05 p-value
indicates a greater probability exist that they are the same. This demonstrates there were no
difference in the ETTs and VAP reduction. Data collection results of ventilator QI will not be
shown as both 12 month time periods remained at 100%. Therefore a two sample t-test was not
conducted. VAP rate/1000 ventilator days were provided by the ID nurse of the CP conducting
facility.
Protection of Human Rights procedure complete
In August 2012 a Collaborative Institution Training Initiative (CITI) course was completed
and a copy of the completion was provided to the Regis University IRB along with an
application for exempt status to conduct the CP (Appendix F). Protection of human rights
procedure was completed and approved by the Regis University IRB who granted exempt status
in February 2013, and the IRB at the facility where the CP was conducted granted approval for
retrospective data collection (Appendices G and H). There was no harm that could come to the
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patients the data was collected on as a result of this CP and there was no breach of
confidentiality. The source of the data in this CP is also available publically. All data collected
was retrospective in nature. In addition, all data provided and collected remained secure within
the facility where the CP was conducted in a locked cabinet or password protected computer.
Equally important, along with data collection, treatment procedures, and protocols discussed in
this project plan and evaluation section, as stated earlier there were no identified issues with
feasibility, risks or unintended consequences.
Instrumentation Reliability/Validity and Intended Statistics
For reliability of data, a confidence interval set at a 95% range was implemented. This
indicates the data falls between two standard deviations from the mean which is therefore closely
banded and signifies no abnormalities. For validity the data collection was validated based on the
outcomes results.
Data Collection and Treatment Procedure
This author collected data on VAP rates for years 2011and 2012 on March 1, 2013 from the
ID nurse of the facility where the CP was conducted. In addition the ID nurse provided the
ventilator days for 2011 and 2012. The CCU nurse manager provided the ventilator QI data. The
MK tube was in practice in 2011, and one VAP incidence was reported. The KCHVLPMC ETT
was in practice in 2012, and two VAP incidences were reported in that year. All VAP incidences
were on adult ICU patients intubated and MV while hospitalized in the ICU. After the data was
provided it was used solely for the purpose of the CP and has since been returned to the facility
where the CP was completed, and will remain secure within that facility.
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Project Findings and Results
Organized by Objectives
The main goal of the CP was to provide the best EBP interventions possible and assure the
most favorable outcome to the intubated and MV adult ICU patient was achieved.
The main objectives were to first, determine if there are decreased VAPs with the KC ETT
compared to the MK; second, did compliance to the VB remain 100%; and third, calculate the
number of ventilator days over the same time period, and fourth, calculate the number of VAP
incidence in the same time period. The outcome plans were to first, evaluate equally the
relationship between the KCHVLPMC ETT in a 12 month period compared to the MK ETT in a
comparable period on VAP incidence. Second, assess compliance of VAP prevention strategies,
which included the VB from the ventilator QI data during both time periods of ETT use. Third,
calculate the number of ventilator days over the same periods of time. Fourth, calculate the
number of VAP incidence in the same time periods.
Key Elements and Instrumentation Findings and Statistical Data/Reliability of Findings
The methodologies applied on the retrospective CP outcome findings and results were the use
of the SPSS program used for the predictive analysis aspect of the project. To support the
validity of the findings this included the application of the two-sample t-test, along with a
probability value (p value) based on 0.05, and the data results were tabulated on the SPSS
program. In addition, the ventilator QI and VAP incidence data were provided by the nurse
manager of CCU during the time periods of both ETTs, and was confirmed by the ID department
coordinator. Equally important, the confidence interval of 95% was used to aid in the analysis,
and supported the reliability of the outcome findings.
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Results Discussed According to EBP
The four main objective outcome plans project findings and results arranged in a question format
Outcome 1): was the number of VAPs different with the KC ETT compared to the
MK?
Outcome results using the two sample t-test in evaluating equally the twelve month periods
the KC and MK showed that there was no significant difference between the two tubes and the
number of VAPs/1000 ventilator days, and based on the 95% confidence interval (CI), and the p
value of (p = 0.67). The two tubes showed also that there was no significant difference in the
patient care outcomes.
Outcome 2): Did compliance to the VB remain 100%?
Outcome results on the evaluation of the VB compliance shows that the bundle compliance
remained at 100% for both twelve month time periods. Therefore, a two sample t-test was not
conducted because the standard deviation is zero for both years, there was 100% compliance
year one and year two.
Outcome 3): Was the number of ventilator days different during the two time
periods?
Outcome results on the number of ventilator days using the two sample t-test revealed there
was a significant difference between the numbers of ventilator days for the two periods, the MK
year 2011 is 580 ventilator days, and the KC year 2012 is 821 ventilator days. This was based on
a CI of 95% and a p-value of (p = 0.02). The results may have been different given more data
from previous years. Typically a two sample t-test is used for larger data sets that allow for more
variation in the data. The facility where the data was collected reported in 2012 the ventilator
days of 821 was the highest recorded data point in their measured history. In addition, the nurse
manager of CCU when asked if there was possibly a huge difference in the patient days for 2011
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and 2012, offered data that revealed there were approximately 3720 patient days in 2011,
whereas the patient days for 2012 were approximately 4660; a difference of approximately 900
more patient days in that year (B. Seward, personal communication, July 1st 2013). The rate ratio
was about the same between the two groups 580/3720 is 0.155 for 2011, and 821/4660 is 0.176.
So the occurrence of MV patients between 2011 and 2012 was really not that huge of a
difference.
Outcome 4): Was the VAP incidence different during the two periods
Outcome results on the number of VAP incidence for the two time periods January, 2011 to
December, 2011 and January, 2012 to December, 2012. There is no significant difference
between the two one year periods, based on the 95% confidence interval (CI), the p value of (p =
0.67); the VAP rate/1000 ventilator days was 1.7 for the 2011 period, and was 2.4 for the 2012
period. This outcome measured the difference in the VAP incidence between the two one year
periods. If both tubes were used at the same time during both years, there could have been a
significant difference between the two tubes. Also, outcome number one and outcome number
four have the same results because of the use of the different ETTs during the two one year
periods. Again if both tubes were used at the same time the results may be different.
The final question is:
In adult ICU patients undergoing oral intubation while hospitalized in ICU, do patients who
are orally intubated with the KCHVLPMC ETT have fewer VAP’s than those who are intubated
with other commercially designed High Volume Low Pressure ETTs like the MK? From a
statistical standpoint based on outcome number one, it indicated there is no significant difference
between the two tubes and the number of VAPs/1000 ventilator days, based on the 95%
confidence interval (CI), and the resulted (p = 0.67). p value. However from a clinical aspect the
increase in ventilator days in 2012, the reported increase in CCU patient days, along with some
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reported staffing concerns and the credible literature support for the newer designed
KCHVLPMC ETT, it is worth stating that along with these findings, perhaps a longer study
would change outcome number one differently. Therefore, it is also worth seriously considering
increasing the length of the data collection in another future study on this same subject of
concern.
Limitations, Recommendations, and Implications for Change
Limitations
There are several limitations identified in the CP. First, this was a small snapshot of two equal
12 month periods where retrospective data was obtained to determine if the design of the KC
ETT was better at reducing VAP than the replaced MK ETT. If the time periods would have
been possible over a longer period of time, it may have made a significant difference. Yet in
prior years when the MK ETT was the main tube used for intubations, there were years when the
VAP rates were higher than the reported two incidences during the 2012 calendar year. Add to
this, the patient days in ICU for year 2011 when the MK was in place there were approximately
3720 days, and in 2012 when the KC was being used, the patient days were approximately 4660
days. Although this data was not requested as part of the CP retrospective data provided by the
facility where the project was conducted it was made available and was recognized as a possible
element in the matter. Equally important, both patients who did develop VAP had underlying
predisposing issues, and the two pneumonias were based on the old CDC criteria that included
the MV patient’s temperature graph, the daily complete blood count (CBC), the sputum culture
results, and the daily chest X-ray (CDC, 2012). These complex cases had a potential pneumonia
diagnosis prior to intubation, which made prevention difficult. However VAP was detected early
and appropriate antibiotic therapies were initiated. The first case was a patient admitted with
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acute respiratory failure (ARF) due to a trauma incident several days earlier, and suffered
multiple broken ribs and was diagnosed with bilateral pulmonary emboli, pneumonia, and had a
reported possible aspiration due to the presence of a possible bowel obstruction which was
associated with the use of a pain medication given while at home and prior to admission. The
second case arrived in the emergency room with ARF and that day failed multiple attempts on Bi
PAP to hopefully prevent needing intubated, and also had an underlying pneumonia and possible
aspiration prior to admission. These two cases also failed the attempts taken to keep them from
needing further ventilator support in the form of intubation and M V in the first place. Every
possible early intervention and VAP prevention strategy was adhered to, but in spite of this a
VAP did occur. Both cases also required multiple procedures and tests were performed in other
departments and required these patients be in the flat position during the time of the tests being
performed. There are always going to be cases like these that carry such high risk factors, but
hopefully more can be learned as further research into the benefit the newer designed ETT can
play in the prevention of VAP is conducted. Nonetheless there remains a growing want to reduce
VAP, and a growing need to do so, from both the customer/patient and the healthcare industries
as a whole.
Yet another identified limitation during the CP data collection timeframe was that the hospital
where the data was obtained went through a merger with another healthcare organization.
Although this had no impact on the CP, it did have an impact on the organization as a whole
where the project was being conducted. Sorting through the merger process generated higher
than average stress and anxiety levels within the healthcare staff. There was a multitude of
staffing issues occurring at the same time leaving some unfilled job vacancies. It was during this
time period that both VAP incidences occurred. These variables can lead to an unpredictably
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higher nursing workload, and can contribute to higher than usual job dissatisfaction. It is well
documented these types of issues can show the way for increased HAIs like VAP to occur, and
augments job frustration levels (Aiken, et al., 2009).
Recommendations
Based on the findings of the CP, the main recommendations for practice changes are as
follows. First, continue a multifaceted VAP prevention approach that includes continuous
compliance to VB protocols as stated earlier, along with pharmacological antibiotic support and
other general measures such as early extubation, aspiration prevention, and decontamination
strategies as simple as proper hand hygiene each time, every time, by everybody. In addition, a
multidisciplinary approach that includes continuous education and daily ventilator QI, along with
further investigation into newer technologies such as the design of the ETT to prevent
contamination and aspiration in the M V patient. Second, continue to use the KCHVLPMC ETT
for intubations and M V longer than 48 hours. Based on the outcome of the retrospective
statistical data where the results of the two sample t-test showed no significant difference in VAP
rates between the MK and the KC tubes, there is really no strong evidence against the utilization
of this tube in the prevention of VAP, and there is sound evidence as stated in the literature
review in supporting the use of this ETT design. In addition, based on all the statistical outcomes
of the CP, in the future the findings from this project will be pursued further. From a clinical
standpoint, strict adherence to the VB and other prevention strategies will now include daily
surveillance and monitoring of the intubated ICU adult patient starting day one of MV, and
consist of observation and collection of the patient’s positive end expiratory pressure (PEEP) and
fraction of inspired oxygen (FiO 2 ) levels in hope of recognizing early indications of a developing
ventilator associated event (VAE), as defined by the CDC (CDC, 2012).
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The implication for change requires putting evidence into practice when things that work are
recognized as such. Once areas for improvement are recognized it is essential standards of care,
policies, and procedures to prevent infections such as a VAP must be developed and strictly
supported and adhered to by all levels of the organization, because preventing HAIs is the
responsibility o f every employee o f the organization.
A multifaceted, multidisciplinary, and multi-professional approach is paramount to move any
initiatives forward. It should start with education and reinforcement, and getting all staff
involved which may call for hospital-wide reporting of HAI rates and their types. Barriers to
change must be anticipated and determined how they will be dealt with. Providing adequate
nursing and respiratory staff is very important; and are essential tools to assure the delivery of
high quality care to the M V patient. In addition, provide adequate supplies and make them
readily available to promote adherence to VAP prevention. Do daily QI monitoring on all MV
patients, and perform and document daily surveillance and monitoring of the PEEP and FiO 2
levels starting day one of MV. Equally important, report adherence to the VB protocol and VAP
rates monthly at nursing staff meetings. In addition continue to support the utilization of the KC
ETT for intubation expected to be longer than 48 hours until further evidence indicates there is a
better ETT available that deceases VAP incidences. Last, continue to conduct frequent literature
reviews on the subject of VAP prevention and the use the newer designed ETTs in preventing
this HAI, to assure that the best evidence based practices are made available to the adult ICU
M V patient population.
Summary
The CP was the final step of the DNP program. It reflected a demonstration of synthesis and
mastery of an advanced subject within the practice of nursing by the student completing their
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final academic steps (Zaccagnini & White, 2011). The purpose of a CP was to improve a practice
and or a patient care outcome and also set the tone for continuous improvement through EBP
interventions (Zaccagnini & White, 2011).
The purpose of this paper was to provide in writing the CPs problem recognition and
definition, review of evidence, project plan and evaluation, project findings and results,
limitation, recommendations, and implications for change, and did the use o f newer designed
ETT like the polyurethane KCHVLPMC ultrathin tube result in a decrease in VAP rates
compared to other HVLP like the MK ETT designs. Further investigation into the role the ETT
design can play in the reduction of a VAP was pursued. From starting out with the practice issue
of concern, and using PICO; a PICO statement was created, and data was collected that
supported no changes in practice from the current use of the KCHVLPMC ETT was necessary.
The MV critically ill ICU patient is at high risk for developing VAP, and it is evident that better
patient care outcomes can be achieved using a multifaceted prevention strategy approach that
includes the use of the KCHVLP ETT. The final question was answered, in adult 18 years and
older patients undergoing oral intubation while hospitalized in ICU, do patients who are orally
intubated with the KCHVLPMC ETT have fewer VAP’s than those who are intubated with the
MK ETT? The answer was that there was no significant difference in the VAP incidence when
the adult patient in ICU was intubated and kept on mechanical ventilation for longer than 48
hours with either ETT the KC or the MK.
VAP is a pervasive and costly HAI greatly associated with the use of instrumentation to
maintain the airway and the ETT selected to achieve ventilated passage. Even though many
factors contribute to the development of a VAP, a multifaceted prevention approach seems to
still be the best strategy. The CP was just a small snapshot comparing two ETTs effectiveness
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against VAP and it is apparent from the systematic review that larger RCT before any definitive
practice change can be recommended must be accomplished. It is evident further investigation
into the role the ETT and other prevention strategies plays in the reduction of a VAP must
continue to be pursued.
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fact possible
tracheal dam age can
occur. Poly ETTprotected against
early onset o f a
V AP and an
association to
reduction in
antibiotic use. N o
clinical data
available on the
HV LP Poly ETT.

The use o f m odified
ETT regardless o f
the design have not
decreased VAP
incidence, shorter
vent days, or higher
survival rate.

G ood study data
strongly supported
by experts like
B lunt, Deem ,
K ollef, K olobow ,
Lorente, and Rello,
P t population could
have been identified
specifically in
categories o f > than
48 hr M V and <
than 48 hours. Also
w ere they ICU adult
pts etc.

N one
listed

System

Level-I

C onsideration

M ainly

A Phase 1/11
clinical trial on
cardiac pts and a
phase 111
random ized
m ulticenter trial
on 1500 pt
intubated > than
24 hrs. w ith an
antim icrobialcoated ETT. A
study on ETT
w ith SSD in over
700 cardiac surg.
Cases, and in a
m ulticentered
trial o f 333 pts
using the SSD
ETT. In a pilot
clinical trial o f
134 cardiac
surgical pts on
the polyurethane
microcuff.
Literature review

Before and after

M any factors

STR: The authors

N one

The small
study did
report that
rem oval o f
oral secretion
before
position
change can
reduce VAP
incidence and
m ortality
incidence; all
at a low cost.
It supports the
C apstone in
the logic that
sim ple
prevention
strategies
done
consistently
can reduce
VAP
incidence and
be conducted
at m inim al
cost. It is
done
routinely
anyw ays w hy
n o t always
prior to
position
changes.
This article
definitely
support the
PICO
healthcare
problem o f
how b est to
prevent VAPs
and the need
for further
research into
the im pact
new er
designed
E T T ’s can
have on VAP
reduction.

I liked the
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preventive
strategies
for
ventilator associated
pneum onia,
Critical
care,
16(210), 1-

doro,
A.,
Bittner
, E., &
Berra,
L.
(2012)

VAP;
prevention

atic
Review
o f m ost
relevan
t
studies
support
ing the
use o f
novel

& II

o f novel
preventive
strategies for
V AP prevention
that have
clinical studies
supporting their
benefits.

A d u lt ICU
intubated
M V pts

o f credible
studies done on
V AP prevention
strategies.

Estim ating
the
proportion
of
healthcareassociated
infections
that are
reasonably
preventable
and the
related
m ortality
and costs.
Infection
Control A nd
H ospital
Epidem iolo
gy, 32(2),
101-114.

Craig,
A.,
M itche
ll, M .,
Doshi,
J.,
A garw
al, R.,
W illia
ms, K.,
&
Brenna
n, P.,
(2011)

PUBM ED :
Estim ating
the
proportion
o f HAI

System
atic
Review
and
figures
from
the
N ationa
l
N osoco
m ial
Infectio
ns
Surveill
ance
(N N IS)
System
s. The
N ationa
l
H ospita
l
D ischar
ge
Survey
and the
A m eric
an
H ospita

Level-ISystema
tic
Review

To estim ate the
proportion o f
H A I in the U.S.
hospitals that
are preventable
and has a high
m ortality and
cost factor.

V aried

H A I Incidence,
A ssociated
M ortality and
R isk Reduction.
Systematic
Review o f
interventions to
reduce HAI, and
ranges o f
preventable risk
reductions, and
systematic
review o f cost
factors

study H ead o f bed,
oral care w ith
chlorhexidine gel,
sedation vacation
and v en t w eaning
protocols reduced
VAP rate. Early
tracheotom y
procedure in a R C T
did n ot reduce VAP
incidence. R C T
using pneum atic
devices did not
reduce V AP rate.
R CT o f SSD E T T
reduced VAP
incidence. R C T o f
silver-coated ET T
com pared to
standard ET T VAP
rates w ere lower.
R etrospective assess
w ith the
polyurethane tube vs
a standard ETT
show ed a reduction
in V A P rates. M eta
analysis o f R C T
associated w ith the
use o f probiotics
reported a reduction
in V AP rates.
A s m any as 55% o f
VAP m ay be
preventable with
current EB P
strategies VAP
carries a high
m ortalityand
prevention can save
considerable costs.

contribute to the
cause o f VAP. VAP
prevention strategies
being used today are
still n ot creating a
Zero VAP
prevention. A m ong
other prevention
strategies that need
to be evaluated is
the use o f m odified
ET T such as SSD,
coated tubes and
alternative cu ff
designs. Pt
positioning, kinetic
therapy, and
probiotic
adm inistration m ust
be furthered studied
in this on-going
battle to reduce
VAP incidence.

used w ell selected
studies for their
system atic review.
LIM : There is room
for bias against
sm aller RCT.

reported

article an d the
author’s
conclusion
that w ere
based on
credible
studies. I fully
agree that
there m ust be
on-going
research
efforts to find
other
prevention
strategies to
reduce the
incidence o f
VAP. This is
w hy I selected
VAP
prevention as
the PICO
healthcare
issue.

E ven with
preventable
strategies for V AP a
zero V AP incidence
m ay n ot be
attainable. Each p t
carries a set o f
unique risk factors.
M ore research is
needed on
prevention o f HAI.

The strength and
lim itations w ere not
listed out b u t it is
obvious to
determ ine that ju st
doing s systematic
review w ould lend
validity to the data.
On the other hand
there is ro o m for
uncertainly in the
estim ates on the
proportion o f HAI,
there is also n ot a
specific population
group, and w hat
determ ine a
preventable HAI
death w hen there
could be other risk
factors n o t known.
C ost estim ates
could have been
collected from fair
to poor designs that
the study was
concluded on

N one
listed

H A I nay
never be
totally
preventable
b u t w ith EBP
strategies we
can hope to
reduce these
incidences.
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Prevention
ventilator
associated
pneum onia
in adult
sowing
seeds o f
change.
Chest,
130(1), 251260.
w ww.chestj
ournal.org

Craven
s, D.,
(2006)

N ew
endotracheal
tubes
designed to
prevent
ventilatorassociated
pneum onia:
do they
m ake a
difference.
R espiratory
Care, 55(8),
1046-1055.

Deem,
S., &
Treggi
ari,
M .,
(2010)

PUBM ED :
antibiotics;
evidencebased data;
guidelines;
IH I=Instit
ution for
H ealthcare
Im provem
ent; V AP
ventilator
associated
pneum onia
; intensive
care;
prevention
of
hospitalacquired
pneum onia
(H AP)

PUBM ED :
Systematic
review of
m ultiple
w ell
designed
RCT.
K eyw ords:
nosocoial
pneum onia
; infection;
subglottis
endotrache
al tube;
ventilator
associated
pneum onia
; VAP;
m ortality;
m orbidity.

l
A ssocia
tion.
Syste m
atic
Review
that
conduc
ed data
com pil
ed from
the
review
focused
on
VAP
prevent
ion
strategi
es of
adult
populat
ions
and
emphas
is on
new
concept
s.
Literatu
re
Review
and
collecti
on o f
historic
al data
from
the
articles
results
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L evel-ISystema
tic
Review
of
creditab
le RCT,
clinical
studies
and
experts
in the
field.

P revention o f
V AP and
im plem entation
o f cost-effective
strategies and
investigating
barriers to their
im plem entation
s am ong
facilities and
healthcare
providers.

L evel-ISystema
tice
Review

Pathogenesis o f
V AP and the
role that the
ETT plays
along w ith
recom m ended
V AP prevention
strategies.

A dults who
are
m echanicall
y
ventilated.

ICU
patients;
size o f
population
varied.

Retrospective
data provided
from resources
like the IHI, and
RCT.

V AP increases
possible m ortality
20 to 70 % in
m edical ICU; costs
estim ated
$40.000/case; and
accounts for approx
25% o f all ICU
infections and >
than 50% o f
antibiotic use.

A m ultidisciplinary
prevention team
approach w ill led by
a Cham pion is
recom m ended to
help set priorities,
benchm ark goals,
analyze data and
sow seed for change
that prom otes risk
reduction.

Star: C raven is the
head o f the ID
departm ent at
L ahey Clinic
M edical Ctr and has
w ritten several
m anuscripts on
V AP prevention he
is seen as an expert
and seeks out other
experts as w ell like
R ello. Craven
yearns to prevent
V AP incidence and
reduce occurrence
using m ultiple
strategies.

No
source
listed.

I see Craven
as a
C ham pion
h im self
against VAP
incidences. I
have read
other articles
w ritten by
him . I have
also seen his
article's
inform ation
used by other
experts such
as J. Rollo,
M . Kollef,
and M.
B o n ten all
experts in
their ow n
right on the
subject o f
VAP
prevention..

M o st data w as
collected via a
varied
quantitative
m ethod.
Exam ples: A
retrospective
study on 4543 pt
at 59 U.S.
hospitals found
m ortality rate
w as as high as
29%. C ost for a
V AP can be as
hig h as
$48,500/case. A
m eta-analysis o f
five studies on
subglottis ETT
reveals a 50%
reduction inV A P
incidence. A
sm all R C T on
cardiac surgery
p t w ho w ere
intubated w ith
the polyurethane
cuffed ETT like
the K CH V LP
E T T and the
M allinckrodt
ETT found that

See above. In
addition VAP
incidence are
expensive, and are
largely related to the
ETT. The
prevention strategies
w ill b e m ost
effective w hen
m ultifaceted
approach w hich
includes infection
prevention, proper
positioning o f pt,
oral care, and early
rem oval o f the ET T
regardless o f the
type. M ore research
into intubation
techniques and the
effects o f the new er
designed ETTs.

M ores studies need
to be conducted in a
setting that
reproduced the
actual clinical
situation that
w arrants intubation
in the first place and
in context w ith a
bundle approach to
prevent VAP.

Str: S. D eem and
M . Treggiari are
affiliated w ith the
A nesthesia
D epartm ent and
both are w ell
respected in the
Respiratory Care
and A nesthesia
healthcare
profession. The
article w hich was
com piled on a very
good sources o f
data adds
creditability to the
findings w hich
w ere m ulticenter,
m eta-analysis, and
R C T sources.
Lim itations: N o
actual research was
conducted by the
authors.

No
source
listed

O nce again
these authors
references
other experts
like Rello,
K ollef, and
M iller. I agree
m ore research
into the
possible
advantages o f
the E T T to
prevent VAPs
m ust be done.
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Strategies in
the
prevention
o f ventilator
associated
pneum onia.
Therapeutic
A dvances in
R espiratory
disease,
5(2), 131141.

Diego,
M ., &
R estre
po, M .,
(
2011).

PUBM ED :
H ospital
acquired
pneum onia
, ICUrelated,
preventive
m easures
ventilator
associate
pneum onia

Eviden
ce
based
review
of
literatur
e

L evel-IIIEvide
nce based
w ell
conduct
ed
systema
tic
review
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V AP prevention
clinically
relevant
pharm acologica
l and no
pharm acologica
l interventions
to prevent VAP.
O w ing to the
im portance o f
this condition
the
im plem entation
o f preventive
m easures is
param ount in
the care o f
m echanically
ventilated
patients. There
is evidence that
these m easures
decrease the
incidence o f
V AP and
im prove
outcom es in the
intensive care
unit. A
m ultidisciplinar
y approach,

ICU
intubated
and
m echanicall
y ventilated
patients.

V AP rate w ere
reduced form
5.5/100 to
2.8/100 v ent
days. A nother
random ized trial
com pared a
polyurethane
tube, a subglottis
tube and a
conventional
tube and found a
significant
reduction in VAP
fro m the
specialized tubes
(22% vs 8%).
M ore research is
needed.
A ntibacterial
coated ET T that
w ere in an
experim ental
setting show
little benefit to
VAP prevention
over the other
ETTs and
actually w ould
cost more.
L iterature review
based on EB P
outcom es. N o
pharm acological
M easures
E vidence grade
and
Pharm acological
M easures
E vidence Grade.
Standard
precautions
L ev el I, Oral
decontam ination
L ev el II, Hand
hygiene Level I
,Selective
digestive
decontam ination
L ev el II, S taff to
patient ratio
L ev el II, Silvercoated
endotracheal
tube Level I,
Semi seated
position Level I,
D aily sedation
breaks L evel II,
A dequate
Endotracheal

The preventive
m easures for VAP
include four
categories: (1)
general m easures,
like infection
control (K ollef
1999) (2) early
extubation, (3)
prevention o f
aspiration,
M easures such as
daily interruption o f
sedation and
pursuing a protocol
fo r early extubation
are associated w ith
shorter duration o f
m echanical
ventilation [W ood et
al. 2007;H orst et al.
1998; K o llef et al.
1997; Saura et al.
(4) decontam ination.
Similarly, a
prospective clinical
study o f critically ill
patients, who
rem ained in the
sem i seated position
o f 30 degrees for the

The author found
based on the
evidence related to
the pharm acologic
and
nonpharm acologic
therapeutic
m aneuvers involved
in the prevention o f
VAP. O wing to the
hig h cost, m orbidity,
and m ortality o f
VAP, preventive
m easures are
param ount in the
care o f m echanically
ventilated patients.
There is evidence
th at these m easures
decrease mortality
and im prove
outcom es in the
IC U ,and include
general m easures,
early extubation,
aspiration
prevention, and
decontam ination. A
m ultidisciplinary
approach, continued
education, and

W ell review ed
based on the experts
on the subject o f
V AP prevention.
Some o f the
literature w as from
as far back as 1994
b u t still very
pertinent today
based on V AP rates
and incidence
nationw ide and
current VAP
prevention
strategies..

Dr
Restrepo
was
supporte
d by the
N ational
Institute
o f H ealth
and
N ational
H eart,Lu
ng and
B lood
Institute.

This one
article
supports the
need for more
research on
the prevention
o f VAP
incidence. It
w as w ell done
and the level
o f evidence
w as very
strong and
therefore
creditable.
The PICO and
healthcare
problem for
the C apstone
stalw artly
reflect the
outcom es and
conclusion.
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continued
education, and
ventilator
protocol are all
essential.
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c u ff pressure
Level II,
D rainage o f
subglottic
secretions Level
II, A voidance o f
circuit
m anipulation
Level II, Early
extubation Level
1 Evidence
G rade: Level I
(high): evidence
com es from w ellconducted,
random ized
controlled trials.
Level II
(moderate):
evidence com es
from welldesigned,
controlled trials
w ithout
random ization
(including cohort
patient series and
case_control
studies) and
system atic
analysis not
collected in a
random ized
fashion. Level III
(low): evidence
com es from case
studies and
expert opinion.

first 24 hours o f
m echanical
ventilation, and had
a low er incidence of
V AP com pared w ith
patients positioned
at less than30
degrees [K ollef et
al. 1999], Several
agents have been
studied for oral
decontamination.
These include use o f
chlorhexidine, and
povidone iodine. It
has failed to show
any significant
benefit over placebo
in preventing V AP
in a large
random ized trial
[K ollef et al. 2006],
The association o f
m icroaspiration w ith
VAP is clearly
established
[Valencia et al.
2007; Craven and
Steger, 1996; Valles
et al. 1995; M ahul et
al. 1992; Torres et al.
1992], The
incorporation o f an
ETT w ith an
ultrathin
polyurethane
m em brane cu ff (7
m m com pared w ith
50 m m in the
conventional cuffs)
that reduces the
form ation o f
channels and the
escape o f subglottic
secretions to the
distal airw ay has
been used
(K im berlyClarkM icrocuff_)
[D ullenkopf et al.
2003], W hen
com pared w ith a
conventional tube,
this modality, in
addition to the
subglottic secretion
drainage, had a
significant decrease
in the incidence o f
early and delayed
VAP [Lorente et al.

ventilator protocols
ensure the
im plem entation o f
these measures.
Future research w ill
continue to
investigate
cost/benefit
relationships,
antibiotic resistance,
as w ell as new er
technologies to
prevent
contam ination and
aspiration in in the
mechanically
ventilated pt.
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V entilatorassociated
pneum onia:
current
status and
future
recom m end
ations,
Journal o f
C linical
M onitoring
and
C om paring,
(24), 161
168.
A sking the
right
question.
Journal o f
Em ergency
M edicine,
33 (6), 571
573.

Technology
advances in
endotracheal
tubes or
prevention
o f ventilator
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U pdate
d
review
of
current
literatur
e

L evel Isystema
tic
review
o f w ell
designe
d RCT

Study aim is to
review the
pathogenesis
and
epidem iology
and the current
and future
recom m endatio
ns on V AP
prevention
strategies.

NA

R eferences from
highly
recognized
experts on V A P
prevention
strategies like:
Cook, Kollef,
Lorente, R ello, to
nam e a few.

Pubmed:
K eyw ords
EBP
asking the
right
questions

NA

NA

NA

NA

NA

MD
C onsult’s
full-text
literature
database.
Technolog

Literatu
re
Review

Level I

Review the
literature
regarding the
recent advances
in ETT tech.
targeted at VAP

M /S IC U pt
m echanicall
y ventilated
(M V ) >
than72 hrs,
in Spain,

R C T results from
1994 to 2010;
RCT,
retrospective
controlled, and
prospective RC

Efrati,
S.,
D eutsc
h, I.,
A nton
elli,
M .,
H ocke
y, P.,
R ozen
blum,
R.,
(2010)

CINAHL,
VAP,
pathogenes
is,
epidem iolo
gy, clinical
practice
guidelines,
prevention

Engber
g, S.,
&
Schlen
k, E.,
(2007)

Fernan
dez, J.,
Levine
, S.,
and
R estre

technology

2007]. The
incorporation o f an
E TT w ith a dorsal
channel for
subglottic secretion
aspiration is
recom m ended as a
preventive strategy
w hen considering
the high cost o f
developing V AP,
low risk, and proven
benefit, especially in
patients
m echanically
ventilated for more
than 48 hours [Rello
et al. 2002]. The
pathophysiology o f
V A P involves a
secondary
colonization o f the
upper respiratory
tract by nosocom ial
pathogens,
accum ulation o f se
N ot cited in the
article

Strong International
and N ational
recom m endation for
m ore technological
com bination o f
solutions based on
the ETT. Subglottis
suctioning,
optim izing E T T cu ff
pressure and
ultrathin cu ff ETT
designs.

0

0

M ost R C T revealed
decreased VAP
incidences. K o llef et
al (2008) using the
silver-coated EE T
cu ff concluded V AP

M ultiple prevention
interventions such
as ventilator bundles
com pliance and the
use o f new er E T T
along w ith

Supportive
evidence for the
C apstone P IC O but
nospecific
identified IC U pt
population or data
from R C T in the
article; ju s t general
good inform ation.

None
listed

Strong
support for
the PIC O and
identified
healthcare
problem
w hich is VAP
and w ay to
prevent
incidence.

NA

No
source
listed

R C T strongly
supports the
findings; the
system atic review
w as done including
highly recognized

None
noted

This w as an
inform ative
article on
asking the
right PIC O
question to
obtain the
b est outcome.
This article
w as m ost
helpful early
on the EB P
PIC O
development.
This is a
strong article
that supports
the Capstone
P roject and
places strong
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associated
pneum onia,
Chest,
142(1). M D
C onsult fulltext
database.
DOI
10.1378/che
st. 11-2420

po, M.,
(2012)

ic
A dvances
in E E T for
prevention
o f V AP

A re
specialized
endotracheal
tubes and
heat-andmoisture
exchangers
cost
effective in
preventing
ventilatorassociated
pneum onia?
R espiratory
care, 55(2),
184-197.

Gentil
e, M .,
&
Siobal,
M .,
(2010)

PUBM ED :
V AP
prevention
; heat-and
exchange;
polyuretha
ne cuff;
endotrache
al tube;
silvercoated;
nosocom ia
l
pneum onia
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prevention.

Literatu
re
Review
of RCT
and
metaanalysi
s

Level-I

V A P prevention
is a m ulti-facet
priority o f the
intensive care
team and can
include the use
o f specialized
airw ays and
heat-and moisture.

France,
China, The
N etherlands
and pt M V
> than 48
hrs, in
China and
France,
cardiothora
cic pt in
IC U in the
U.S. and
Spain.
Subglottis
secretion
devices
(SSD ) and
non SSD,
Tapered
ET Tcuffs
and
Polyvinylch
loride cu ff
(PV C ) cuff,
Cylindrical
ETT cuffs
and PVC,
Silvercoated ET T
and non
silver
coated
ET T.Sam pl
e sizes w ere
from 18 pts
G irou et al
(2004) to
1503
ptK o llef et
as (2008).
No
specifics
found in the
article

studies.

trends w ere delayed
and a reduction in
VAP incidence with
shorter term ed MV.
ETT colonization o f
pathogens play a
key role in V A P
incidence, The
new er designed ETT
w ith SSD,
polyurethane cuffs,
cylindrical tapered
and silver-coated
ETTs show prom ise
but m ore studies
m ust be com pleted
and therefore costeffectiveness o f
im plem entation o f
these new er ETT
designed m ust be
given consideration.

pharm acological
and non
pharm acological
strategies m ust be
studied further.

data trials for 1994
to current.

D ata retrieved
fro m studies:
Six R C T an d a
m eta-analysis o f
five studies
found that SSD
found that this
type o f ETT
reduced V A P by
nearly h a lf (risk
ratio o.51,
95% C I 0.37
0.71) in a
heterogeneous pt
population w hen
M V 72hours is
required. One
study done by
Young et al
com pared H V LP
to LV LP ET T

N o t w ell
docum ented b ut the
article does say that
VAP prevention
may best be
achieved w ith a
m ultifaceted
m ultidisciplinary
bundle o f simple
interventions such
as hand hygiene,
position HOB
elevated, oral
hygiene, Studies o f
these new er devices
has been under
pow ered for risk vs
benefit, cost
effectiveness
mortality, safety,
and potential injury.

Sam e as above;
current evidence is
still inconclusive on
the effects o f the
specialized ETT
H M E , cost and
prevention w hen it
com es to VAP.

STR: The data
provided w as from
w ell docum ented
and recognized
resources such as
Lorente, and Kollef.
This article set the
tone for further
investigation into
novel prevention
strategies to reduce
V A P incidence.
LIM : N one listed
b u t the article itself
w as n ot clear and
lacked holding
interest. It w as not
w ell laid out or
labeled. H ard to
read and follow.

evidence on
the need for
further
research into
the prevention
role new er
designed ET T
along w ith
other VAP
prevention
strategies play
in V AP
reduction.

None
reported

I d o n ’t really
have much
com ment. It
w as a
redundant
literature
review that
offered no
new
prevention
strategies for
VAP. Yes it
does support
the capstone
on the sense
that m ore
research is
needed on the
subject o f
V AP
prevention
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Is there a
benefit to
m ultidiscipli
nary rounds
in an open
trauma
intensive
care unit
regarding
ventilatorassociated
pneum onia?
The
A m erican

Johnso
n, V.,
M angr
am,
A.,
M itche
ll, C.,
Lorenz
o, M .,
H ow ar
d, D .,
&
Dunn,
E.,

M ultidisci
plinary
rounds
(M DRs);
V AP

R etrosp
ective
chart
review

L evel III
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To determ ine
the im pact o f
the institution o f
M D R s in a
traum a ICU
regarding VAP.

G roup 1-Pts
w ith V AP83 total
from 2003
to 2005
before
im plem enta
tion o f
M D R m ean
age 40.5,
and G roup2 Pts with
V AP-49
fro m 2005

stated these
E T Ts reduced
aspiration. A
R C T by L orente
et al revealed in
polyurethane
cu ff E T T w ith no
SSD V AP w ere
31 or 22% o f 140
pts com pared to
ETT w ith SSD
11 or 8% o f the
140 pt
population.
Silver coated
ETT K eller et al
report in a
m ulticentre R C T
there w as a
35.9% VAP
reduction in a
2003 pt
population M V
greater or equal
to 24 hours from
54 o f the centers,
and a 4.8 vs.
7.5% low er VAP
incidence am ong
pts incubated for
greater than 24
hours. IN a m eta
analysis H ess et
al found a lower
risk o f V AP w ith
heat-and
m oistureexchange (H M E)
than w ith heat
m um m ification.
There was
disputed
controversy and
added risk with
all o f these ETT
and H M E
methods.
R etrospective
data collection
fro m chart
review o f trauma
IC U pts who
required
m echanical
ventilation (M V)
fro m 2003 to
2007 no longer
than 48 hours.
U sing the
International
C lassification o f

C urrent evidence is
still inconclusive.

F rom 2003 to 2007
there w ere 805 pt
requiring M V and a
total o f 4508 v ent
days. Significant
difference w as seen
before M D R and
after M DR. Group
1-Pts w ith VAP-83
total in 2414 vent
days show a ratio o f
34.3 V APSs /1000
v ent days from 2003
to 2005 before

and th at m ost
o f the article
review ed thus
far concludes
that
prevention
w ill probably
be achieved
m ore my
m ultifaceted
and
m ultidisciplin
ary measures.

B ecau se this w as an
open traum a ICU
the need for M D R
w as supported w ith
the inform ation this
retrospective data
provided. W ith the
need to elim inate
V A Ps and the
im pact this disorder
w ill have on future
reim bursem ent the
im plem entation o f
M D R in the support

STR: The use o f
retrospective data
proved valuable in
supporting the need
for M D R and the
reduction o f V APs
in open traum a
ICU. LIM : Only
done at one facility
and only one open
traum a ICU. I do
feel the results
w ould b e close to
the sam e in other

None
reported

I really liked
this article. It
w as easy to
follow , w ell
laid out to see
the results and
read the
m ethods used.
It also
supports the
fact th at V A P
prevention is
a m ulti-facet
approach and
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Surgeon,
75(12),
1171-1174.

(2009)

Current
practice in
airway
m anagem ent
:a
descriptive
evaluation,
A m erican
journal o f
critical care
, 19(2), 168172.

K jone
gaard,
R.,
Fields,
W ., &
King,
M ., L.,
(2012)

F rom the
Journal
A irw ay
M anagem e
nt Practice

D escrip
tive
com par
ative
design

Level-V

Silvercoated
endotracheal
tubes and
incidence o f
ventilatorassociated
pneum onia,
JA M A ,300(
7), 805-813.

Kollef,
M .,
B eckel
e, A.,
A nzuet
o, A.,
verem
akis,
C.,
Kerr,
K.,
M argo
lis, B.,
C raven
, D.,
Robert
s, P.,
A rroli
ga, A.,
H ubm
ayr,

PUBM ED :
Silver
coated
ETT and
V AP
incidence

Prospec
tive
RCT

Level-I

47
to 2007
after M D R
im plem enta
tion m ean
age 43.3.

D iseases 9th
R ev isio n codes
and using the
center o f D isease
C ontrol and
Prevention
(C D C ) criteria
fo r VAP.

im plem entation o f
M D R and G roup-2
Pts w ith V A P-49 in
2094 v en t days
show a ratio o f 23.4
V A Ps/1000 v ent
days from 2005 to
2007 after M D R
im plem entation. (p
= 0.04)

to decrease V A P is
evident.

types o f ICU s w ith
M DR.

V alidate the
need for
com pliance to
E B P ’s to reduce
V A P incidence

41
R egistered
N urses
(R N ) and
25
R espiratory
Therapist
(RT)

A descriptive
com parative
design w as used
on 41 R N s and
25 R T w ho
m anaged IC U pt
on MV.
D escriptive and
inferential
statistics w ere
used to analyze
the data
collected.

There was
significant
difference existed
betw een R N and R T
for hyper
oxygenation before
suctioning. R T
instilled saline and
rinsed the closed
system w ith NSS
m ore than RN. R N
gave oral care more
than RT.

RN s and RTs
differed
significantly in the
m anagem ent o f pts
on the vent. The
standard o f care
should be consistent
using EBP
interventions.

STR: Over 2/3 o f
the survey
distributed w ere
returned. Lim :The
survey w as done at
one location

None
reported

To determ ine if
V A P incidence
could be
reduced using
the sliver-coated
E T T thus
reduces
m ortality rates.

A total o f
9417 adult
pts w ere
screened
betw een
2002 and
2006. A
total o f
2003 pt
expected to
be M V for
24 hours or
longer w ere
random ized

P ts w ere
assigned to
undergo
intubation w ith 1
o f 2 H V L P ETTs
sim ilar except
one was silvercoated.

V AP w ere 4.8%
w ith pts intubated
w ith the slivercoated ET T and
7.5% w ith the
uncoated ETT

P t receiving
intubation w ith the
silver-coated ETT
h ad a reduction in
the V AP incidence.

Str: V ery w ell
designed R C T and
w ell supported by
statistical data.
Safety for both
groups was never
an issue. Lim:
Other factors like
secondary problem s
the pts m ay have
been experiencing
that contributed to
their M V situation.
A nd, the tim e o f
w hen the
respiratory culture
w as obtained varied
w ith pts.

R esearch
grant
from C.
R. B ard
Inc.

props up the
need to look
further at
V AP
prevention
strategies
those
currently
practiced and
novel ones as
well.
The fact that
there is a
difference in
the care
provided to
vented pts by
R N s and RTs
could im pact
the pt
outcom e and
be a factor in
the
developm ent
o f a VAP.
This article
strongly
supports that
consistent
com pliancy to
V AP
prevention
strategies by
all healthcare
m em bers
directly
caring for the
M V p t could
reduce V AP
incidence.
The study was
conducted
w ell b u t there
are factors
that could
have
influenced to
outcomes.
Some pt
developed
their VAP
before the 48
h o u r period
and thus may
have had
contributing
risk factors
that m ade
them a V AP
regardless o f
w hat tube was
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R.,
R estre
po, M .,
Auger,
W ., &
Schinn
er, R.,
(2008)

The
ventilator
care bundle
and its
im pact on
ventilatorassociated
pneum onia:
a review o f
the
evidence.
N ursing in
Critical Car,
16(5), 222
233.

Lawre
nce, P.
Fulbro
ok, P.,
(2011)

PUBM ED :
M icroaspir
ation,
VAP,
N osocom i
al lung
infection,
ventilator
care
bundle

Literatu
re
Review
from 10
researc
h
studies

Level - I

To critically
analyze recent
research that
has investigated
ventilator care
bundle (VCB)
use and the
im pact on VAP
outcomes.

F rom all the
m eta
analysis
listed the
studies
were
conducted
on adult
ICU M V
pts at
multiple
tim es and in
multiple
facilities.

R etrospective
data analyzed
fro m the 10
research articles.

Some studies
indicated th at the
w hen the VCB was
used consistently the
VAP incidences
w ere reduced. But,
due to identified
lim itations m ore
thorough evaluation
o f data collected on
each VCB indicator
m ust be m ore tightly
im plem ented in
order to carefully
evaluate the
effectiveness o f the
VCB strategies.

This paper strongly
supports that there is
a lack o f
standardized care
fo r M V pts w ith or
w ithout the VCB
im plem entation.

STR: The article
supports that M V
pts are not
consistently
receiving
standardized EBP
interventions. LIM :
D ata w as not
clearly illustrated in
this article Tools
that som e o f the
studies used for
their data collection
w ere n ot provided.

None
reported

Prevention
of

Leasur
e,A.,

D atabase
Cochrane:

H istori
cal

Level-I
and II

Exam ine the
effectiveness o f

H um an
subject

A ssessm ent o f
data extrapolated

The presence or
absence o f a VAP;

The goal o f the
study w as to

STR: The
system atic review

N one
reported

use for
intubation. I
detected some
bias in results.
The article
w ill support
the Capstone
in the sense
that it
supports the
need to look
closer at the
design o f the
ETTs as a
m ethod to
reduce V AP
incidence.
Perhaps a
reduction in
V AP
incidence can
be associated
with
com pliancy to
VCB b ut the
data and
m ethod upon
w hich Q uality
Im provem ent
(Q I) is
collected
m ust be k ept
consistent.
EBP
intervention
should b e the
standard for
all M V pts
regardless
w hat
institution the
intubation
occurs. This
article m ay
not
necessarily
support the
C apstone but
it does
support the
fact that
prevention o f
a V AP starts
the m om ent
that p t is
intubated
regardless o f
w hat E T T is
used.
The
system atic
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ventilatorassociated
pneum onia
through
aspiration of
subglottis
secretions. a
systematic
review and
m eta
analysis.
D im ensions
o f Critical
Care
Nursing,
31(2), 102
117.

Change
Theory by
K u rt Lewin.
R etrieved
October 8,
2011, from

Stirlen
, J.,
Shu
Hua
Ku,.
(2012)

Prevention
, VAP,
subglottis
secretions,

D esign
using
system
atic
review
and
metaanalysi
s based
on
studies
that
focused
on
subglot
tis
secretio
n
drainag
e, used
prospec
tive
design,
sample
d only
hum ans
, and
had a
control
group

0

Retrieved
O ctober 8,
2011, from
http://curre
ntnursing.c
om /nursin

No
researc
h
design
but this
theory

NA
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subglottis
secretion
aspiration in
reducing VAP
thus reduce
V A P rates, and
tim e being M V,
m ortality, and
LOS

hospitalized
in an ICU
w ho w ere
intubated
and MV.

fro m the selected
studies, and tw o
review er
independently
assess the studies
fo r appropriate
m ethodology,
quality, and then
u sed a
standardized
checklist to
appraise and
sum m arize the
results. If there
w ere
disagreem ents
they w ere
resolved through
further
discussion o f the
tw o reviewers
and a third party.

M ortality rate; VAP
incidence/1000 vent
days; D ays to onset
o f a V AP; D uration
o f M V ; LOS

exam ine the
effectiveness o f
SSD aspiration on
V A P reduction, The
findings o f the
system atic review
dem onstrated a 50%
reduction in V AP
rates w hen an ETT
had SSD com pared
to a ETT w ithout
SSD. A tw o day
shorter duration o f
M V w as also seen in
m ost experim ent
groups than in m ost
control groups
across studies.

w as w ell selected
by highly
recognized RCT.
The use o f the
tables m ade the
article easy to
follow. LIM : I see
som e potential for
bias as no articles
w ere selected to
show the negative
side o f SSD
aspiration.

NA

NA

NA

NA

NA

NA

NA

review was
w ell done and
presented in a
clear and
logical order
in the article.
These authors
really took
som e tim e to
prepare the
data and made
a deliberate
effort to
rem ain none
bias to the
results.
However,
there are
article and
studies that
dispute the
SSD
aspiration
method.
There are also
strong
indications
that even
better
designed ET T
and cuffs m ay
also reduce
V AP
incidence and
cause less risk
o f harm to the
pt. The use o f
tables in the
article m ade it
easy to see
the results o f
the data. I
really enjoyed
this article.
W ell done.
This supports
a C apstone
objective o f
bringing
about
standardized
care to the
M V ICU
adult
population.
The K urt
L ew in
Change
Theory has
been w idely
used in
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http://curren
tnursing.co
m /nursing_t
heory/chang
e_theory.ht
ml

N ew issues
and
controversie
s in the
prevention
of
ventilatorassociated
pneum onia.
A m J Respir
C rit Care
M ed. 182,
870-876.

g_theory/c
hange_the
ory.htm l

Lorent
e, L.,
Blot,
S., &
Rello,
J.,
(2010)

PUBM ED :
Issues;
controversi
es;
prevention
;VAP;
cuff;
coated
tube;
tracheotom
y;
hum idifier

of
change
w ill be
used in
the
im plem
entatio
n of
change
s to
practice
based
on the
results
and
outcom
es
identifi
ed in
the
Capsto
ne
Project.
Syste m
atic
review
o f RCT
or
metaanalysi
s
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changing
practices in
the nursing
profession. It
is clear,
concise, and
easy to
understand at
m ost levels o f
healthcare
workers.
U nfreeze,
m ove to the
new level o f
change and
Refreeze. The
plan is to
im plem ent
this m odel if
change in
practice is
warranted.

L evel-I

To review
current V AP
prevention
strategies that
w ere n ot clearly
recom m ended
in the past. and
m ake strong
argum ent for
their application
in to d ay ’s
practice to
prevent VAP.

So me
studies
stated adult
MV
population
in IC U ’s
som e did
n ot clearly
specify the
population.

H istorical
retrospective
design data
critiqued from
highly respected
studies using the
criteria; if the
recom m endation
s w ere supported
by a R C T or
m eta-analysis,
and there w ere
no reservations
about the
benefits, harm , or
cost. If the
recom m endation
s by R C T or
m eta-analysis it
w as defined as
m ore research
needed.

B ased on the
credible studies that
m et the criteria o f
the authors a b rief
summary: ETT w ith
SSD -recom m ended;
E TT w ith ultra thin
cu ff and SSD -w orth
consideration; one
study w as done by
L orente in 2006.
ETT w ith ultra thin
cu ff no SSD- w orth
consideration.
C onstant pressure
inflation cuff-m ore
research needed.
E TT w ith SSD and
LV LP constant
pressure inflation
cuff--m ore research
needed. D evice to
rem ove biofilm m ore research
needed. Saline
instillation before
suction-m ore
research needed.
Early tracheostom yw orth
recom m endation.
E TT silver coatedrecom m ended. H eat
m oisture exchange
(H M E)-w orth
consideration

O bviously m ore
research is needed
and should be on
going on the best
approach to V AP
prevention. A ll m ust
consider benefits,
harm and cost

STR: definitely
looked at the best
studies th at have
been done on M V
pts. It w as fair and
balanced. V ery
clear, concise in the
recom m endations
and rationale for
their
recom m endations.
W here there was
som e concern on
sam ple size or data
results the authors
did define that m ore
research is needed.
LIM : Lack
inform ation on cost
effectiveness,
m ortality, duration
o f M V , LO S, and
specific population.

Stijn
B lot did
receive
$1001$5000
for
Covidien
and
$1001$5000
form
Cook
C ritical
Care in
lecture
fees.

C ovidien does
m anufacture
the
M allinckrodt
H V LP and
Seal G uard
ETTs endorse
by L orente
and lecture
fees w ere
provided to
B lot this
could lead to
a som ew hat
bias in their
opinions and
recom m endati
ons. O ne o f
the studies in
the system atic
review was
conducted by
Lorente. The
system atic
review was
w ell
com pleted
and the
criteria for the
article chosen
w ere very
precise. This
review
definitely
supports the
Capstone
P roject in the
fact th at w hen
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A
polyurethan
e cuffed
endotracheal
tube is
associated
with
decreased
rates o f
ventilatorassociated
pneum onia.
Journal
C ritical
Care, 26(3).
280-286.

M iller,
M.,
Arndt,
J.,
K onkl
e, M .,
Cheno
weth,
C.,
Iwashy
na, T.,
Flahert
y, k .,
&
Hyzy,
R.,
(2010)

CIN AH L
and
PUBM ED :
VAP;
nosocom ia
l
infections;
M V ; ETT

O bserv
ational
researc
h
design

LevelIII
controll
ed trial
no
random i
zation
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To determ ine
w hether the use
o f polyurethanecuffed ET T use
results in V A P
incidence
reduction.

A ll adults
MV
throughout
a large
academic
hospital
from 2007
to 2008.

P roduct
replacem ent o f
the E T T from a
conventional
ETT to the
polyurethanecu ff
(K C H V LPM C )
and retrospective
appraisal o f V AP
rates before
im plem entation
and after
im plem entation
o f the new ETT
and com pleting a
tim e-series
analysis.

V A P rates decreased
for 5.3% /1000vent
days before the use
o f new E T T to 2.8%
/1000vent days

U se o f the new
polyurethane cuffed tube was
associated w ith a
decreased rate o f
V A P incidence.

STR: The
observation data
w as real-tim e. The
observers w ere able
to collect data at the
tim e and elim inate
som e extraneous
variables. The
m ulti-facet
healthcare team can
b e observed real in
real life settings. A
generalization
based on
observation can be
m ore situational
this can account for
the com plexity o f
m ulti-group
behaviors such as
com pliance to V ent
bundle protocols.
LIM : O bservation
o f real practice over
m any shifts is tim e
constraining. Bias
am ong observers
can occur. Subject
source m any be
unequal.

Study
partially
funded
by
K im berle
y Clark
Corp.
(K CC)
w hich
m anufact
ures the
K CHVL
PM C
ETT.D r
Hyzy
received
& 5800.0
0
consultat
ion fee
for KCC
and a
$6000.00
educatio
nal grant.

m ulti-facet
prevention
strategies are
im plem ented
V A P rate can
be reduced.
M ore research
is needed to
continue the
surge tow ard
better VAP
prevention
healthcare
practices.
M ore
consideration
on ETT
selection m ust
continue and
further studies
on the effects
m ust be done.
The fact that
this w ell done
observation
study w as
heavily
funded by one
o f the authors
lends itse lf to
a strong bias.
The
researcher
m ay only see
w hat they
w ant to. See.
Source o f
subjects could
b e questioned.
A ny group
that is studied
especially via
observational
m ethod can
be skew ed to
som e degree.
The article
did conclude
that V A P still
ho ld a high
m ortality and
healthcare
cost. I f a
sim ple change
in ET T use
reduces VAP
it is w orth it.
This article
definitely
supports the
Capstone
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Subglottic
drainage o f
secretions
reduces
V AP (m eta
analysis;
review).
C ritical Care
M ed, 39(8),
1985-1991.

M usce
dere,
J.,
Rew a,
O.,
M cK e
chnie,
K.,
Jiang,
X.,
Laport
a, D.,
&
H eylan
d, D .,
(2011)

PUBM ED :
Subglottic
secretion
drainage
(SSD );
prevention
; VAP;
m eta
analysis

N ew
tracheal
tubes to
prevent

Nseir,
S.,
(2011)

M ED LIN E
: VAP;
new ETT;
evidence

Searche
d
com put
erized
databas
es,
referen
ce lists
and
persona
l files
RCT of
M echa
nical
ventilat
ed
(M V )
pts
com par
ing
standar
d ETTs
to SSD
ETTs
Studies
w ere all
metaanalyze
d for
prim ary
outcom
es o f
V AP
and
second
ary
clinical
outcom
es.
N one
noted

52

L evel-I

A spiration o f
secretions
containing
bacteria
pathogens that
causes VAP.
ETTs w ith SSD
as a prevention
o f VAP.

PC T
equaling
N =2442

Literature
R eview ; Study
identification:
A ll relevant
articles using
reputable
databases. Study
selection criteria:
R C T o f adult
M V critically ill
p t ; D ata
synthesis:
P rim ary
occurrence o f
VAP. Secondary
ICU and hospital
L ength o f stay
(L O S ) m ortality,
antibiotics, safety
data. Prim ary
and secondary
analysis: Only
studies that m et
the inclusion
criteria and
subgroups o f
high-quality
studies using a
m edian score.

LevelIV

Source o f
evidence that
supports the use
o f new er

None
provided

R etrospective
literature review
supporting
evidence.

13 random ized
clinical trials that
m et the inclusion
criteria w ith a total
o f 2442 random ized
patients. O f the 13
studies, 12 reported
a reduction in VAP
rates in the SSD
arm ; in m eta
analysis, the overall
risk ratio for V AP
w as 0.55 (95%
confidence interval,
0 .4 6 -0 .6 6 ; p <
.00001) w ith no
heterogeneity (I2 _
0%). The use o f
SSD w as associated
w ith reduced ICU
LO S ( 1.52 days;
95% confidence
interval, 2.94 to
0.11; p = 03);
decreased duration
o f m echanically
ventilated (1.08
days; 95%
confidence interval,
2.04 to 0.12; p =
03), and increased
tim e to first episode
o f V A P (2.66 days;
95% confidence
interval,1.06 - 4.26;
p = 001). There was
no effect on adverse
events or on hospital
or IC U m ortality
Silver coated ETT
w ere found to
reduce V AP but
there is lim itation on

In those at risk for
V AP, the use o f
ETTs w ith SSD is
effective for the
prevention o f V AP
and m ay be
associated with
reduced duration o f
M V and ICU LOS.

STR: W ell done
and w ell supported
by RCT. LIM :
Some sources
provided m inim al
data and the
m ajority o f studies
used only one type
o f E T T com pared to
the SSD ETT.

None
reported

Further designed
studies are needed
before a ETT
recom m endations

STR: Strong and
w ell stated opinion
LIM : The opinion
m ay n ot be shared

None
reported

P roject and I
have no
conflict o f
interest or
strong bias
w ith any ETT
m anufacturer.
Strong choice
o f references
like
D ullenkopf,
Lorente,
Kollef, and
R ello; these
are experts on
the issue o f
V AP
prevention.
The use o f a
system atic
review and
m eta-analysis
again show
that a
m ultifaceted
approach
including
novel
prevention
strategies like
ET T designs
m ust be given
strong
consideration.

I do share the
opinion o f the
author and I
agree that
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ventilatorassociated
pneum onia:
w here is the
evidence?
C ritical
Care,15(6),
459.

53
designed ETTs
vs the standard
tube
M ED LIN E:
V AP; new ETT;
evidence

Preventing
ventilatorassociated
pneum onia
D oes the
evidence
support the
practice?
JAM A,
301(23),
2534-2538.

O ’Gra
dy, N.,
M urry,
P.,
Ames,
N.,
(2012)

M ED LIN E

V entilatorassociated
pneum onia
bundled
strategies:
an evidencebased
practice,
W orldview s
on evidencebased
nursing,
5(4), 193204.

O ’Kee
feM cC ar
thy, S.,
Santia
go, C.,
Lau,
G.,
(2008)

Cochrane
or
CINHAL:
VAP;
m ethodolo
gy;
nosocom ia
l infection;
intubation.
; adult;
ventilator
bundles;
EBP;
restricted
to
quantitativ
e studies

the studies that
made a
recom m endation
only. Same w as true
for polyurethane
cuffed tubes only a
recom m endation. It
is clear th at m ore
R C Ts need to be
conducted on new er
designed ETTs.

can becom e the
standard o f practice
in M V pts.

by those w ho have
p u t tim e and effort
into the studies that
have been
conducted.

STR: Strong food
for thought. I to
have seen som e
cases w here I did
feel the pt had a
V A P b u t it was
other risk factors
like an aspiration
prior to intubation
that caused the
pneum onia. LIM :
This w as one case
study, I am sure
there are others out
there to support the
need for consistent
im plem entation o f
V A P prevention
strategies like V A P
bundles.
STR: W ell
organized
system atic review
w ith the data
com ing from
studies various
databases.
Investigators used
the interrater
reliability The acute
Physiology and
Chronic H ealth
Evaluation
(A PA C H E) scores
w ere used to assess
severity o f illness
and supported
validity o f som e o f
the outcomes.
LIM : Inconclusive
evidence w as
revealed,
m ethodologies w ere
som etim es
inadequate,
reporting o f data
w as casual in some

Case
study

LevelV II

Strong need for
available studies
to include
interventions
that im prove
patient
outcom es before
they are
im plem ented as
prevention
approaches in
clinical practice.

A adult
ICU p t
intubated
and reintubated

C ase study done
on one M V pt.

D ifficulty with
diagnosing VAP
that resulted in a
death.

In spite o f VAP
prevention bundles
V A P is still a
leading k iller in
IC U ’s. Before
clinicians adopt the
V A P bundle for all
M V p t’s evidence
needs to b e credible
and strong based on
im proved pt
outcomes.

Syste m
atic
Literatu
re
Review
w as
conduct
ed in
M ED LI
NE,
CIN HA
L,
Cochra
ne, and
PsycIN
FO

Level-I

To provide a
review o f
literature on
V A P bundles,
practice,
definitions. To
discuss
know ledge o f
practice and
actual clinical
settings
prom otion. To
identify need
for further
research to
prevent VAP.

Critically ill
adult pts
w ith VAP

A study w as
evaluated on
certain inclusion
criteria: O riginal
quantitative
research done in
English, bundled
practices w ere
exam ined and
clinical outcom es
o f the critically
ill adult with
V A P w ere
assessed.

O utcom es:
O utcom es that are
identified in the
m ajority o f studies
both clinical and
process; V A P rate,
frequency, num ber
o f ventilator days,
ICU LO S, m ortality
rates, com pliance
rates. Results: Two
studies used the
CD C definition for
V AP; num ber o f
V A P/num ber o f
ventilator days x
1,000 and reported a
decrease o f VAP
0 .0-2.7 per 1,000
v en t days. . One
study reported a
strong relationship
betw een V A P rates
and com pliance; in
21 ICU s that had a
95% com pliancy
rate VAP decrease

M ethodologically
strong R C T are
necessary to
determ ine the
effects o f EBP. A
strong
organizational
conceptual
fram ew ork to
im plem ent the
transform ation o f
know ledge to
practice is essential
and depends on
effective leadership
to cham pion the
cause. EBP
interventions are
decreasing V AP
rates and m ust be
continued and
closely monitored.

Preventing
; V AP

None
reported

None
reported

m ore research
into the best
preventive
strategies to
reduce V AP
m ay lie in the
new er
designed
ETTs. This
opinion does
support the
need for my
Capstone
focus.
Excellent
article. It does
support the
need for more
research to be
done on V A P
prevention
strategies and
considering
m ore novel
strategies
currently not
included in
V A P bundles
like new er
ET T designs.
This supports
m y C apstone
focus.
This w as a
system atic
review (SR)
done in
Canada. I do
agree th at the
authors
conclusion
found that
R C T do carry
the highest
level o f
evidence for
practice, it is
also im portant
that the data
is as strong
and correct as
possible.
W hat the SR
did reveal was
that even
am ong
facilities and
direct care
providers
there is
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studies, inconsistent
protocols w ere
seen, study results
w ere careless a in
som e studies.
Internal and
external validity
com prom ised.

from 6.6 to 2.7 per
1,000 v ent days. A
general trend seen in
m ost studies w as
that the num ber o f
v ent days decreased
from 6.1 to 3.5 days.
The LO S in ICU ws
variable as som e did
not report this data.
M ortality rates also
w ere not addressed
in the m ajority o f
studies. The
com pliance rate to
V AP prevention
bundles was
increased in m ost o f
the studies up 20 % .

A nalysis o f
overall level
o f evidence
behind the
institute o f
healthcare
im provem en
t ventilatorassociated
pneum onia
guidelines.
Southwest
Journal o f
Pulm onary
and C ritical
Care, 3: 40
48.

Padrno
s, L.,
Bul,
T.,
Pattee,
J.,
W hitm
ore, E.,
Iqbal
M .,
Lee,
S.,
Singar
ajah,
C., &
Robbi
ns, R.,
(2011)

PUBM ED :
VAP;
V AP
bundle

Syste m
atic
review
of
literatur
e;
studies
w ere
require
d to be
prospec
tive and
controll
ed in
design.

Level o f
evidenc
eI
through
IV
variable

A ssessm ent o f
the quality o f
evidence
underlying
recom m endatio
ns from one
m edical
regulatory
organization the
Institute o f
H ealthcare
Im provem ent
(IH I) regarding
guidelines for
V A P prevention
and or V AP
bundles.

Each study
had a
different
population
size (see
results) but
com bined
total o f
5097 pt
audits
representin
g 5800 vent
days, and
each author
exam ined
their ow n
ICU s w here
they
w orked for
evidence o f
a
correlation
betw een
guidelines
com pliance
and the
developm en
t o f VAP.
IRB
approval

R etrospective
data collection
from individual
studies that m et
the criteria for
selection. Studies
w ere required to
be prospective
and controlled in
design. Only
studies
dem onstrating a
reduction in V A P
w ere considered.
The A m erican
Thoracic Society
grading system
w as used to
assess the
underlying
quality o f
evidence for the
IH I V AP
guidelines and
includes levels 1
high, 11 m od, 11
low, and 1V no
evidence o f
im provement.

Elevation head o f
bed-31 articles-8
used, level 11- m od
recom m endations;
D aily sedation
vacation- 66
articles-4 used-level
111- w eak
recom m endation;
D aily readiness to
w ean or extubate-47
articles-3 used-level
111-weak
recom m endation;
D aily spontaneous
breathing trial-29
articles-1 usedlevel-111- w eak
recom m endation;
Peptic ulcer
diasease-52 articles9 used-level 1Vw eak
recom m endations;
D eep venous
throm bosis
prophylalxis-14
articles-2 usedlevel-111-w eak
recom m endation.

As seen above they
w ere unable to show
that im proved V AP
guideline
com pliance
correlated w ith a
reduced incidence o f
VAP. A gencies like
the IH I should show
restrain in guideline
form ation based on
the opinion or
e=w eak conflicting
evidence. Only
those w ith strong
backing evidence
should be
designated as a
guideline.

STR: D rakulovic et
al. conducted a
R C T 86 M V pts on
HOB. K ress et al.
conducted a R C T
on 128 adult pts
M V for sedation
vacation. The other
outcom es did not
indicate the study
used. A large
population was
used for this
system atic review.
LIM : A ll data cam e
from the Phoenix
V A hospitals. No
data on negative
consequences if the
IH I guidelines w ere
n o t m andated and
m onitored.

None
reported.

inconsistency
in the practice
and
interventions
that M V p t’s
receive. It
does support
the Capstone
in the sense
that m ore
research is
needed to
investigate
effective
strategies that
are
standardized
and do
support the
reduction in
V AP
incidence.
W O W this
has given me
food for
thought. This
could be bias
opinion; as
w ell as
selection in
the studies
used. I do
agree that
m ore studies
are needed
and there has
to b e m ore
investigation
into novel
prevention
strategies like
the ETT
designs and to
aid in
determ ining
the best
standardized
practice that
M V pts
should
receive. M ore
w ork need to
b e done
especially
w hen hospital
reim bursem en
t is based on
prevention.
The question
is can V A P
ever be

NR706C_PageJo_wk8CAPSTONE PROJECT

A
random ized
trial o f
dental
brushing for
preventing
ventilatorassociated
pneum onia.
Chest,
136(2), 433
439.

Pobo,
A.,
Lisboa
, T.,
R odriq
ues,
A.,
Sole,
A.,
M agret
, M .,
Trefler
, S.,
G om ez
, F., &
R ello,
J.,
(2009)

PUBM ED :
D ow nload
ed from
chestjourn
al.chest.pu
bs by guest
on M ay
15, 2012
w w w .chest
journal.org

Single
blind
prospec
tive
study
of
standar
d oral
care
with
0.12%
Chlorh
exidine
digluco
nate
(standa
rd
group)
vs
standar
d oral
care
plus
electric
tooth
brushin
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LevelII

Potential
relationship o f
oral care to
V A P incidence.
The hypothesis
w as that
im proved oral
care w ith the
electric tooth
brushing m ay
help reduce
V A P incidence.

A large
m ed/surg
ICU at an
urban
teaching
hospital.
IRB
approval.
A ll adult
pts who
w ere
intubated
w ithout
incidence o f
pulm onary
infection
and trialed
w ithin 12
hours o f
intubation if
expected to
be intuabed
for longer
than 48
hours. 147
pts w ere
random ized
74 w ere in
the
toothbrush
group.

A prospective
single-blined
R C T o f adult pts
intubated for >
than 48 hrs.
C ontrolling for
exposure to
antibiotic
treatm ent, pts
w ere random ized
to oral care every
8 hrs w ith 0.12%
C hlorhexidine
digluconate
(standard group)
vs standard oral
care plus electric
tooth brushing
(toothbrush
group). V A P was
docum ented by
quantitative resp
cultures. M V
duration, LOS,
antibiotic use,
and m ortality
w ere all
secondary
outcom es

The groups w ere
com parable at
baseline. V AP
(20.3% vs 24.7% p=
0.55).

O ral care w ith the
electric toothbrush
using 0.12% Chlor
dig is n ot effective
for the prevention o f
VAP.

STR: F irst study to
evaluate a different
oral care protocol.
Intervention simple
and safe. LIM:
Possible type II
errors, possible lack
o f com pliance by
healthcare staff. A
single study. Lack
o f standard oral
care
recom m endations.

None
reported

Levels I, II, III

To develop a
V ent bundle and
care practices
for critical care
nurses to reduce
the rate o f VAP.

ICU s in
L ankenau
Hosp. Pa.
on 105 staff
nurses, a
total o f
4709 V ent
days w ere
audited
from Jan
2009
through
Dec. 2009.

The IH I protocol
fo r oral care,
h an d w ashing,
H OB, SSD;
com pliance audit
calculated by
electronic
feedback was
conducted.

A dherence to v ent
bundles increased.
C om pliance for
peptic ulcer dx
prophylaxis, DVT,
sedation vacation,
and elevated HOB
w ere greater than
98%. Com pliance
rate for oral care
increased from 76%
to 96.8%. Readiness
for extubation
reached 92.4%.
V AP decreased
from 9.47 to 1.9/100
v ent days. Saving
from V A P rate
decrease w as
approx. $1.5
million.

Strict adherence to
bundle practices for
V A P prevention,
interdisciplinary
collaboration
im proved patients’
outcom es and
p roduced a m arked
savings in cost.

STR: C om pliance
data w as collected
by Q I staff.
SM A RT approach
d escribed by K o llef
an expert in V AP
prevention was
used. Education
support w as a big
part o f
im plem entation.
Com puter data
com pleted the
calculations. VAP
reduction was
achieved. LIM :
Short tim e fram e
b u t I really d o n ’t
see too many
limitations.

None
reported

g
(toothb
rush
group).
Level
of
Eviden
ce
U sing
evidencebased
practice to
prevent
ventilatorassociated
pneum onia.
C ritical Care
Nurse,
32(4), 41
50.

Sedwi
ck, M.
LanceSmith,
M .,
R eeder
, S.,
Nardi,
J.,
(2012)

R etrieved
from the
actual
journal:
EBP;
VAP;
prevention

Review
of
literatur
e;
studies
with
RCTs,
retrosp
ective
chart
review s
o f data
from
previou
s trials
and
metaanalysi
s.

elim inated. I
say no, b u t it
can be
reduced.
Very
interesting
R C T th at may
p u t to rest the
use o f electric
toothbrush
oral care.
Evidence
does show
that certain
oral care
guidelines
m ay reduce
V A P risk. I
am convinced
that novel and
know n
preventive
strategies
such as oral
care
guidelines
w ill be a
factor in VAP
preventions
strategies in
the future.

W ell done
nurses. I think
I could adopt
m any o f the
strengths
from this
article’s
exam ple for
future use.
Excellent
studies w ere
selected that
are
consistently
referenced by
others for a
resource and
literature
reviews. This
can support
m y C apstone
by
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Endotrachea
l tube cu ff
design and
function.
A nesthesiol
ogy news
guide to
airway
m anagem ent
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Spiege
l, J.,
(2010)

PUBM ED :
N ew
designed
ETT
com pariso
n

Literatu
re
review

LevelV II

O verview o f
new er ETT
designs

A dults and
pediatric
population
is given is
m entioned

N one disclosed

None included

Som e m ajor recent
im provem ents in
E T T cu ff design
have offered
clinicians real
choice in device
usage. C u ff designs
are adding to safety
and V AP
reductions.

LIM :N o real data
and statistics to
back up opinion.

None
reported

W ahl,
W .,
Zalew s
ki, C.,
H em m
ila, M .,
&
Arbor,
A.,
(2011

PUBM ED :
Surgical
ICU;
pneum onia

R etrosp
ective
review
o f all
M V pts
in
m ixed
surgical
ICUs
who
develop
ed
pneum
onia
from
2006 to
2008.

LevelIII

To prove that
m any acutely
injured pts
develop
pneum onia at
the tim e o f
injury in spite o f
m easures to
prevent it.

There w ere
208 M V pts
who
underw ent
bronchoalv
eolar lavage
(BA L)
specimens
h a lf o f
which w ere
perform ed
the first 48
hours o f
adm ission.
IRB
approved.

R etrospective
review o f these
M V pts from
m ixed ICU s who
developed
pneum onia from
2006 to 2008 and
w ere vented >
than 48 hours.

O f the 208 M V pts
who underw ent
bronchoalveolar
lavage (B A L)
specim ens h a lf o f
which w ere
perform ed the first
48 hours o f
adm ission. 58% had
a positive BAL
culture b u t no VAP.
Only 10% o f pts
studied w ith early
BA L h ad no growth.
25 pts w ith a
positive B A L on
early BA L
underw ent repeated
BA L and 16 (64% )
w ere later diagnosed
w ith VAP.

M any intubated pts
in the surgical ICus
h ad evidence o f
early pneum onia or
bac, grow th w ithin
48 hours o f arrival
to the ICUs.
Indicating pt derived rather than
environm ental
acquired source m ay
ad d to V A P risks.

STR: The findings
seem to indicate
that factors o f
developing V AP
can be multiple.
LIM : N o real
deviation o f
m edical and
surgical pts. It was
a small single
centered study.data
that was
retrospective.

None
reported

A N ESTH ES
IO LO G Y N
EW S.COM .
51-56.

Pneum onia
in the
surgical
intensive
care unit: Is
every one
preventable?
Surgery,
150: 665
672.

).

prevention

strengthening
the argum ent
for more
com pliance to
vent bundles
and
m axim izing
the ebp
strategies we
already have.
A great article
and many
studies do
support that
V AP
reduction can
occur w ith the
use o f these
new er
designed ET T
even if it is a
small
reduction.
This is a w eak
level o f
evidence
source but
done better
the author
could have
added greatly
to the need to
investigate
new er ETT
designed
further in the
future to
support the
evidence for
practice.
I feel the
article did
lend som e
m erit to the
possibility
that the
bacteria
sources that
can cause a
V A P is not
easily
contained or
isolated. This
adds to the
vulnerability
o f pneum onia
such as a
V A P if M V in
the already
com prom ised
injured pt.
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Brushing
teeth w ith
purified
w ater to
reduce
ventilatorassociated
pneum onia.
Journal o f
Nursing
Research,
19(4), 289296.

Yoa,
L.,
Chang,
C.,
M aa,
S.,
W ang,
C.,
Chen,
C.,
(2011)

Cochrane:
V entilatorassociated
pneum onia
; oral care;
tooth
brushing;
oral
health;
oral
hygiene

R CT
pilot

L evel-II

Study the
effects in a
neurosurgical
ICU brushing
teeth tw ice daily
w ith purified
w ater on M V
pts to see if
V A P rate w ere
reduced.

N =53 m ale
64.2%
m ean age
60.6.

M V support for
at least 48 hrs,
and no current
pneum onia. Both
groups received
the sam e oral
care. The exp gr
received tooth
brushing with
purified water.
The con gr
received regular
oral care
m oisturizing o f
lips.

N =53 after 7 days o f
tooth brusining
method, V A P rate
w ere low er exp gr
17% than in con gr
71% p<.05.

Protocol using
toothbrush with
purified w ater can
reduce V A P and
im prove oral health
and hygiene.

STR: D esign was
rigorous RCT.
LIM : Sam ple small.
One center.

Grants
by
Taiw an
N ational
Science
Council
and
N ational
H ealth
R esearch
Institutio
n.

The
tracheal
tube:
gatew ay to
ventilatorassociated
pneum onia.
Critical
Care, 15(5),
310-

Zolfag
hari,
P., &
W ynco
ll, D .,
(2011)

PUBM ED :
Trach tube

V iew po
int
article

LevelV II

To explore the
published data
on support for
n ew er ETT and
their potential
contribution to
V A P prevention
strategies.

None listed

N one listed

None listed

The paradigm o f
V A P prevention
strongly favors
m ulti-faceted
strategies aim ed at
reducing aspiration
o f oropharyngeal
secretions. W ith the
increasing w eig h t o f
evidence pointing at
the role o f the
tracheal tube design
and m aintenance o f
adequate cu ff
pressures, is it really
good m edical
practice to continue
to use standard
cuffed tubes?

STR: I do agree
w ith the opinion o f
the authors LIM:
N o strong evidence
for their opinion
w as found in the
article

PSZ has
no
com petin
g
interests.
In the
p ast 3
years,
D W has
acted as
a paid
consultan
t or given
lectures
on V AP
for
Covidien
K im berly
-Clark
and
Bard.

Results could
be seen as
bias based on
the grants.
The small
study w as
interesting
and should be
studied
further. It
could becom e
a preventive
strategy for
V A P if m ore
research is
conducted. At
this tim e I see
it as a
consideration
o f novel
strategies to
prevent VAP.
I do question
a possible
strong bias
and influence
from one o f
the authors.
The article is
n o t w ell done.
It is clear and
concise and I
do agree that
m ore research
b e done on
the new er
designed ET T
and the part
they can play
in VAP
reduction.
This is a main
thread o f my
PICO and
Capstone.
C an using a
new er
designed ET T
reduce V AP
and provide
better pt care
outcom es? I
ho p e to find
some
evidence o f
such a
possibility.
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Appendix B
Conceptual Model for Prevention of VAP (Kane, 2011)
And
Logic Model for DNP Project (Zaccagnini & White) 2011)

Practice Issue of Concern:
•

Ventilator associated pneumonia (VAP) a m ajor source of hospital acquired infections in Intensive Care Units
(ICU's)
Higher m orbidity and m ortality and an overwhelm ing health care cost factor in the intubated adult patient
population.
Evidence show s that a VAP starts with a host factor and pathogen. Knowing this, several different
Prevention strategies must be initiated at the time of the intubation that reduce the host factor and colonization
of pathogens that contribute to a VAP. Craven (2006)

•
•
•

Prevention Strategies

Clinical factors
•

•
•
•
•
•

Implement ventilator bundle that are evidence base
practice driven

Hospital Acquired Infections
(HAI) are common
complications in an ICU
especially in the adult intubated
patient.
Age of pt
Diagnosis of pt prior to
intubation
Past hx o f pt/risk factors
Sputum and blood cultures prior
to intubation
Staff compliance to infection
control standards and VAP
bundle

•
•
•
•
•
•
•
•
•
•

Improve hand hygiene compliancy
Prevent gastric and oral pharyngeal aspiration
Elevate HOB
Daily assessment for weaning and sedation
vacation
Oral care protocol to prevent oral tracheal
secretion contamination
Endotracheal tube cuff management.
Blood Sugar control
DVT prophylaxis
Peptic ulcer prophylaxis
Consider implementing endotubes designed to
be high volume lo pressure micro cuffed

Outcomes
•
•
•
•

Assess vented pt population for VAP using CDC criteria
Assess compliancy of the VAP bundle
Assess decrease incidences of VAP cases
Identify improved pt care outcomes in the adult ICU
intubated pt
Promote a Zero VAP incidence environment
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Project

The evaluation of the effectiveness of Evidence based practice strategies in conjunction with the newer designed ETT
like the KCHVLPMC tube to reduce the incidence of VAP in the ICU in an adult patient population. A reduction in
VAP incidence and improved better patient care outcome are the effective goals to be met.

Problem Identification:

Increased incidence of VAP in spite of vent bundle protocols and 100% quality
indicator (QI) compliance and other evidence based practice (EBP) strategies.

Inputs

—►

Constraints

—

->

- Noncompliance to any
VAP preventive
strategies
- Budget to replace ETT
throughout the
department that
performs intubation
- Existing culture to not
change old system
- Time
- Small sample size due
to small hospital size
150bed acute care
facility
- Data fromone facility

^ - Small 20 bed ICUfor data ^

J

V

J

- Intermittent literature reviews from
numerous search engines for current
EBP interventions to prevent VAP
- Training ofnewproduct and
rationale for change
- Reinforcement of compliancyto
current in place prevention strategies
- Defendingthe rationale for selecting
the KCHVLPMCover another ETT
tubes
- Monitor practice of VAP prevention
strategies among healthcare providers
- Document standard of practice
(SOP) benchmarks using a SOP
Quality Improvement (QI) data
collection form

Outputs

r

1r

r
collection
- Hospital acquired Infection
(HAI) rates
- HAI VAP rates
- Age ofpatient (pt)
- Diagnosis of pt prior to
intubation
- Past historyof pt
- Sputumandblood cultures
prior to intubation
- Staffcompliancyto infection
control standards and
ventilator bundle protocols
- Mortality and Morbidityrate
hospital wide

Activities

y

- Training
- Data collection D/Con
VAP incidence
- D/Con HAI
- D/Con mortality and
morbidityassociated
with VAP
- D/Con ventilator days
- D/Cof length of stay
(LOS)
- D/Con cost
- D/Con HAI rates
- D/Con VAPrates
- Data on nurse/patient
ratios
- D/Con Vent Care QI

\
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Appendix C
Measurement tool/instrument
Context-Specific Database Draft
Month

# of Patients
on Ventilators

Kimberly
Clark or
Mallinckodt

VAP
Compliancy

# of
Ventilator
Days

QI

VAP
Incidences

Ventilator QI
D a te:__________
Auditor’s Initials:
Room #
Medical Record #
Assigned RN Initials
1. Ventilator Order Set on Chart?
2. Ventilator Order Set completed
and signed by the physician?
3. Is it documented that the HOB is
elevated 30-45 degrees at all times?
4. Is a Sage 24 hr oral care kit in the
room?
5. Is mouth care documented every 2
hrs on the CCU flow sheet?
6. Doe the caregiver wash hands or
use alcohol based hand antiseptic
before and after entering the patient’s
room? (observe one caregiver)
7. Is there documentation regarding
daily assessment of readiness to
extubate (“sedation vacation”)?
* See respiratory flow sheet on the
clipboard at the patient’s bedside.
Comments

7a

7p

7a

7p

7a

7p

Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No

Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No

Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No

Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No

Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No

Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No

Yes
No

Yes
No

Yes
No

Yes
No

Yes
No

Yes
No
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Appendix D
Timeframe
Timeframe
The time frame for the retrospective data collection was from February 27, until May 31, 2013.
The data was collected on time and tabulated with results known as of July 4, 2013.
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Appendix E
Budget and Resources Congruent with Objectives and Funding Source Identified
There are no budgetary concerns
- No additional education requirements
- No additional equipment to purchase
- No cost was incurred in the data collection
The KCHVLP ETT is currently implemented into practice (no resource supply issue)
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Appendix F
CITI Collaborative Institutional Training Initiative (CITI)
The RCR for Social & Behavioral Curriculum Completion Report
Printed on 9/17/2012
Learner: Joyce Page (username: jpge)
Institution: Regis University
Contact Information
Regis University

3333Regis BLVD
Denver, Colorado 80221
The RCR for Social & Behavioral: This course is for investigators, staff and students with an interest or
focus in Social and Behavioral research. This course contains text, embedded case studies AND quizzes.
Stage 1. RCR Passed on 09/17/12 (Ref # 8717519)
Required Modules

Date
Completed

Introduction to the Responsible Conduct of Research
Research Misconduct 2-1495

09/17/12
09/17/12

Case Study - Truth or Consequences 2-1217
Case Study - In the Field, No One Will Know 2-1218

09/17/12
09/17/12

Case Study Plagiarism 2-1472

09/17/12

Human Subjects 13566

09/17/12

no quiz
5/5
(100%)
2/3 (67%)
3/3
(100%)
2/2
(100%)
5/5
(100%)

For this Completion Report to be valid, the learner listed above must be affiliated with a CITI
participating institution. Falsified information and unauthorized use of the CITI course site is
unethical, and may be considered scientific misconduct by your institution.

Paul Braunschweiger Ph.D.
Professor, University of Miami
Director Office of Research Education
CITI Course Coordinator
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